Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________________________________

FORM 10-Q

___________________________________________

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 31, 2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission File Number: 001-40348

___________________________________________

UiPath, Inc.

(Exact Name of Registrant as Specified in its Charter)

___________________________________________


Delaware			47-4333187
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
One Vanderbilt Avenue, 60th Floor New York, New York			10017
(Address of principal executive offices)			(Zip Code)
Registrant’s telephone number, including area code: (844) 432-0455

___________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading
Symbol(s)

Name of each exchange on which registered

Class A common stock, par value
$0.00001 per share

PATH

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of December 1, 2023, the registrant had 483,625,511 shares of Class A common stock and 82,452,748 shares of Class B common stock, each with a par value of $0.00001 per share, outstanding.

Table of Contents


		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	1
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Operations	2
	Condensed Consolidated Statements of Comprehensive Loss	3
	Condensed Consolidated Statements of Stockholders’ Equity	4
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	38
Item 4.	Controls and Procedures	38

PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	40
Item 1A.	Risk Factors	40
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	41
Item 3.	Defaults Upon Senior Securities	42
Item 4.	Mine Safety Disclosures	42
Item 5.	Other Information	42
Item 6.	Exhibits	42
Signatures		43

Table of Contents

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), about UiPath, Inc. and its consolidated subsidiaries (“UiPath,” the “Company,” “we,” “us,” or “our”) and our industry that involve substantial risks and uncertainties. All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations or financial condition, business strategy, and plans and objectives of management for future operations, are forward-looking statements. In some cases, forward-looking statements can be identified because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would,” or the negative of these words or other similar terms or expressions. These forward-looking statements include, but are not limited to, statements concerning the following:

•our expectations regarding our revenue, annualized renewal run-rate ("ARR"), expenses, and other operating results;

•our ability to acquire new customers and successfully retain existing customers;

•our ability to increase the number of users who access our platform and the number of automations built on our platform;

•our ability to effectively manage our growth and achieve or maintain profitability;

•future investments in our business, our anticipated capital expenditures, and our estimates regarding our capital requirements;

•the costs and success of our marketing efforts and our ability to evolve and enhance our brand;

•our growth strategies;

•the estimated addressable market opportunity for our platform and for AI-powered automation in general;

•our reliance on key personnel and our ability to attract, integrate, and retain highly-qualified personnel and execute management transitions;

•our ability to obtain, maintain, and enforce our intellectual property rights and any costs associated therewith;

•the effect of significant events with macroeconomic impacts, including, but not limited to, military conflicts and other changes in geopolitical relationships and inflationary cost trends, on our business, industry, and the global economy;

•our ability to compete effectively with existing competitors and new market entrants; and

•the size and growth rates of the markets in which we compete.

These forward-looking statements should not be unduly relied upon or regarded as predictions of future events. The forward-looking statements contained in this Quarterly Report on Form 10-Q are based on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled "Risk Factors" and elsewhere in this Quarterly Report on Form 10-Q, and in the section titled "Risk Factors" and elsewhere in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023 filed with the Securities and Exchange Commission ("SEC") on March 24, 2023 (the "2023 Form 10-K"). Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject, based on information available to us as of the date of this Quarterly Report on Form 10-Q. While we believe such information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. Such statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.

The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments.

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited).

UiPath, Inc.

Condensed Consolidated Balance Sheets

Amounts in thousands except per share data

(unaudited)


	As of
	October 31, 2023		January 31, 2023
ASSETS
Current assets
Cash and cash equivalents	$	1,003,080	$	1,402,119
Restricted cash	444		—
Marketable securities	814,097		354,774
Accounts receivable, net of allowance for credit losses of $1,023 and $2,698, respectively	373,091		374,217
Contract assets	84,164		69,260
Deferred contract acquisition costs	63,553		49,887
Prepaid expenses and other current assets	91,224		94,150
Total current assets	2,429,653		2,344,407
Marketable securities, non-current	—		2,942
Contract assets, non-current	6,078		6,523
Deferred contract acquisition costs, non-current	139,932		137,616
Property and equipment, net	22,504		29,045
Operating lease right-of-use assets	53,711		52,052
Intangible assets, net	16,460		23,010
Goodwill	87,293		88,010
Deferred tax assets	5,143		5,895
Other assets, non-current	26,284		45,706
Total assets	$	2,787,058	$	2,735,206
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable	$	13,664	$	8,891
Accrued expenses and other current liabilities	108,014		76,645
Accrued compensation and employee benefits	100,170		142,582
Deferred revenue	405,837		398,334
Total current liabilities	627,685		626,452
Deferred revenue, non-current	132,600		121,697
Operating lease liabilities, non-current	57,687		56,442
Other liabilities, non-current	7,873		10,457
Total liabilities	825,845		815,048
Commitments and contingencies (Note 11)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding	—		—
Class A common stock, $0.00001 par value per share, 2,000,000 shares authorized; 488,021 and 474,160 shares issued; 484,782 and 474,160 shares outstanding, respectively	5		5
Class B common stock, $0.00001 par value per share, 115,741 shares authorized; 82,453 shares issued and outstanding	1		1
Treasury stock, at cost, 3,239 shares and none, respectively	(52,649)		—
Additional paid-in capital	3,958,795		3,736,838
Accumulated other comprehensive income	3,158		7,612
Accumulated deficit	(1,948,097)		(1,824,298)
Total stockholders’ equity	1,961,213		1,920,158
Total liabilities and stockholders’ equity	$	2,787,058	$	2,735,206

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

UiPath, Inc.

Condensed Consolidated Statements of Operations

Amounts in thousands except per share data

(unaudited)


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Revenue:
Licenses	$	148,068	$	118,175	$	401,407	$	338,875
Subscription services	167,529		130,159		473,880		370,309
Professional services and other	10,324		14,410		27,532		40,848
Total revenue	325,921		262,744		902,819		750,032
Cost of revenue:
Licenses	2,781		3,208		8,336		7,915
Subscription services	28,647		20,578		78,502		63,949
Professional services and other	18,492		18,982		55,736		60,496
Total cost of revenue	49,920		42,768		142,574		132,360
Gross profit	276,001		219,976		760,245		617,672
Operating expenses:
Sales and marketing	191,282		156,469		521,413		527,798
Research and development	84,514		67,341		246,462		203,880
General and administrative	56,024		63,157		172,185		189,130
Total operating expenses	331,820		286,967		940,060		920,808
Operating loss	(55,819)		(66,991)		(179,815)		(303,136)
Interest income	14,483		9,561		41,913		15,057
Other income (expense), net	13,725		888		25,491		(2,523)
Loss before income taxes	(27,611)		(56,542)		(112,411)		(290,602)
Provision for income taxes	3,926		1,182		11,388		10,061
Net loss	$	(31,537)	$	(57,724)	$	(123,799)	$	(300,663)


Net loss per share attributable to common stockholders, basic and diluted	$	(0.06)	$	(0.10)	$	(0.22)	$	(0.55)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	567,036		550,164		562,651		546,087

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

UiPath, Inc.

Condensed Consolidated Statements of Comprehensive Loss

Amounts in thousands

(unaudited)


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Net loss	$	(31,537)	$	(57,724)	$	(123,799)	$	(300,663)
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale marketable securities, net	277		(324)		259		(625)
Foreign currency translation adjustments	(8,625)		(3,873)		(4,713)		(3,321)
Other comprehensive loss, net	(8,348)		(4,197)		(4,454)		(3,946)
Comprehensive loss	$	(39,885)	$	(61,921)	$	(128,253)	$	(304,609)

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

UiPath, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

Amounts in thousands

(unaudited)


	Common Stock						Treasury Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Income		Accumulated Deficit		Total Stockholders’ Equity
	Class A			Class B
	Shares	Amount		Shares	Amount		Shares	Amount		Amount		Amount		Amount		Amount
Balance as of January 31, 2023	474,160	$	5	82,453	$	1	—	$	—	$	3,736,838	$	7,612	$	(1,824,298)	$	1,920,158
Issuance of common stock upon exercise of stock options	898	—		—	—		—	—		1,175		—		—		1,175

Issuance of common stock upon settlement of restricted stock units	4,246	—		—	—		—	—		—		—		—		—
Tax withholdings on settlement of restricted stock units	(1,463)	—		—	—		—	—		(25,697)		—		—		(25,697)
Charitable donation of Class A common stock	281	—		—	—		—	—		4,215		—		—		4,215
Stock-based compensation	—	—		—	—		—	—		85,125		—		—		85,125
Other comprehensive income, net	—	—		—	—		—	—		—		2,462		—		2,462
Net loss	—	—		—	—		—	—		—		—		(31,901)		(31,901)
Balance as of April 30, 2023	478,122	$	5	82,453	$	1	—	$	—	$	3,801,656	$	10,074	$	(1,856,199)	$	1,955,537
Issuance of common stock upon exercise of stock options	1,824	—		—	—		—	—		2,717		—		—		2,717

Issuance of common stock upon settlement of restricted stock units	5,026	—		—	—		—	—		—		—		—		—
Tax withholdings on settlement of restricted stock units	(1,676)	—		—	—		—	—		(27,420)		—		—		(27,420)
Issuance of common stock under employee stock purchase plan	832	—		—	—		—	—		9,313		—		—		9,313
Stock-based compensation	—	—		—	—		—	—		102,148		—		—		102,148
Other comprehensive income, net	—	—		—	—		—	—		—		1,432		—		1,432
Net loss	—	—		—	—		—	—		—		—		(60,361)		(60,361)
Balance as of July 31, 2023	484,128	$	5	82,453	$	1	—	$	—	$	3,888,414	$	11,506	$	(1,916,560)	$	1,983,366
Issuance of common stock upon exercise of stock options	837	—		—	—		—	—		1,516		—		—		1,516
Vesting of early exercised stock options	—	—		—	—		—	—		1		—		—		1
Issuance of common stock upon settlement of restricted stock units	4,639	—		—	—		—	—		—		—		—		—
Tax withholdings on settlement of restricted stock units	(1,583)	—		—	—		—	—		(27,047)		—		—		(27,047)
Repurchase of Class A common stock	—	—		—	—		(3,239)	(52,649)		—		—		—		(52,649)
Stock-based compensation	—	—		—	—		—	—		95,911		—		—		95,911
Other comprehensive loss, net	—	—		—	—		—	—		—		(8,348)		—		(8,348)
Net loss	—	—		—	—		—	—		—		—		(31,537)		(31,537)
Balance as of October 31, 2023	488,021	$	5	82,453	$	1	(3,239)	$	(52,649)	$	3,958,795	$	3,158	$	(1,948,097)	$	1,961,213

Table of Contents


	Common Stock						Treasury Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total Stockholders’ Equity
	Class A			Class B
	Shares	Amount		Shares	Amount		Shares	Amount		Amount		Amount		Amount		Amount
Balance as of January 31, 2022	458,773	$	4	82,453	$	1	—	$	—	$	3,406,959	$	10,899	$	(1,495,946)	$	1,921,917
Issuance of common stock upon exercise of stock options	1,283	—		—	—		—	—		2,683		—		—		2,683
Vesting of early exercised stock options	—	—		—	—		—	—		1,355		—		—		1,355
Issuance of common stock upon settlement of restricted stock units	3,499	—		—	—		—	—		—		—		—		—
Tax withholdings on settlement of restricted stock units	(1,125)	—		—	—		—	—		(24,827)		—		—		(24,827)
Stock-based compensation	—	—		—	—		—	—		102,085		—		—		102,085
Other comprehensive loss, net	—	—		—	—		—	—		—		(458)		—		(458)
Net loss	—	—		—	—		—	—		—		—		(122,561)		(122,561)
Balance as of April 30, 2022	462,430	$	4	82,453	$	1	—	$	—	$	3,488,255	$	10,441	$	(1,618,507)	$	1,880,194
Issuance of common stock upon exercise of stock options	1,418	—		—	—		—	—		1,878		—		—		1,878

Issuance of common stock upon settlement of restricted stock units	3,183	1		—	—		—	—		—		—		—		1
Tax withholdings on settlement of restricted stock units	(1,040)	—		—	—		—	—		(18,922)		—		—		(18,922)
Charitable donation of Class A common stock	300	—		—	—		—	—		5,499		—		—		5,499
Shares issued in connection with business acquisition	570	—		—	—		—	—		2,965		—		—		2,965
Issuance of common stock under employee stock purchase plan	578	—		—	—		—	—		9,070		—		—		9,070
Repurchase of unvested early exercised stock options	(441)	—		—	—		—	—		—		—		—		—
Stock-based compensation	—	—		—	—		—	—		88,533		—		—		88,533
Other comprehensive income, net	—	—		—	—		—	—		—		709		—		709
Net loss	—	—		—	—		—	—		—		—		(120,378)		(120,378)
Balance as of July 31, 2022	466,998	$	5	82,453	$	1	—	$	—	$	3,577,278	$	11,150	$	(1,738,885)	$	1,849,549
Issuance of common stock upon exercise of stock options	1,087	—		—	—		—	—		2,889		—		—		2,889

Issuance of common stock upon settlement of restricted stock units	2,790	—		—	—		—	—		—		—		—		—
Tax withholdings on settlement of restricted stock units	(951)	—		—	—		—	—		(11,998)		—		—		(11,998)
Stock-based compensation	—	—		—	—		—	—		81,305		—		—		81,305
Other comprehensive loss, net	—	—		—	—		—	—		—		(4,197)		—		(4,197)
Net loss	—	—		—	—		—	—		—		—		(57,724)		(57,724)
Balance as of October 31, 2022	469,924	$	5	82,453	$	1	—	$	—	$	3,649,474	$	6,953	$	(1,796,609)	$	1,859,824

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

UiPath, Inc.

Condensed Consolidated Statements of Cash Flows

Amounts in thousands

(unaudited)


	Nine Months Ended October 31,
	2023		2022
Cash flows from operating activities
Net loss	$	(123,799)	$	(300,663)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	16,555		12,993
Amortization of deferred contract acquisition costs	52,828		37,967
Net amortization on marketable securities	(19,556)		501
Stock-based compensation expense	283,025		270,797
Charitable donation of Class A common stock	4,215		5,499
Amortization of operating lease right-of-use assets	9,663		8,555
Provision for deferred income taxes	(1,040)		1,171
Abandonment and impairment charges	—		2,881
Other non-cash credits, net	(4,864)		(1,714)
Changes in operating assets and liabilities:
Accounts receivable	(1,507)		(33,449)
Contract assets	(14,875)		(27,735)
Deferred contract acquisition costs	(71,727)		(69,657)
Prepaid expenses and other assets	17,247		(27,361)
Accounts payable	5,767		2,414
Accrued expenses and other liabilities	22,309		(13,785)
Accrued compensation and employee benefits	(40,590)		(26,096)
Operating lease liabilities, net	(10,296)		(488)
Deferred revenue	30,125		54,232
Net cash provided by (used in) operating activities	153,480		(103,938)
Cash flows from investing activities
Purchases of marketable securities	(1,006,606)		(204,311)

Maturities of marketable securities	576,480		93,298
Purchases of property and equipment	(3,558)		(21,614)
Payments related to business acquisition, net of cash acquired	—		(29,542)
Other investing, net	2,754		(507)
Net cash used in investing activities	(430,930)		(162,676)
Cash flows from financing activities
Repurchases of Class A common stock	(52,649)		—
Proceeds from exercise of stock options	5,421		7,605
Payments of tax withholdings on net settlement of equity awards	(75,495)		(53,300)
Net payments of tax withholdings on sell-to-cover equity award transactions	(645)		(10,132)
Proceeds from employee stock purchase plan contributions	14,253		13,525
Payment of deferred consideration related to business acquisition	(5,863)		—
Repurchase of unvested early exercised stock options	—		(1,493)
Net cash used in financing activities	(114,978)		(43,795)
Effect of exchange rate changes	(6,167)		(7,162)
Net decrease in cash, cash equivalents, and restricted cash	(398,595)		(317,571)
Cash, cash equivalents, and restricted cash - beginning of period	1,402,119		1,768,723
Cash, cash equivalents, and restricted cash - end of period	$	1,003,524	$	1,451,152
Supplemental disclosure of cash flow information
Cash paid for interest	$	515	$	720
Cash paid for income taxes	9,136		19,060
Supplemental disclosure of non-cash investing and financing activities
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options	1		1,355
Value of shares issued in payment of business acquisitions	—		2,965
Payable for marketable securities purchase	9,747		2,894


Loan notes issued in connection with business acquisitions	—		11,433
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid	6,833		2,517

The accompanying notes are an integral part of these consolidated financial statements.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements

(unaudited)

1. Organization and Description of Business

Description of Business

UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. Our AI-powered UiPath Business Automation Platform offers a robust set of capabilities that allows our customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale.

2. Summary of Significant Accounting Policies

Our significant accounting policies are discussed in greater scope and detail in Note 2, Summary of Significant Accounting Policies, in the notes to consolidated financial statements included in the 2023 Form 10-K. There have been no significant changes to such policies during the nine months ended October 31, 2023.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2023, which are included in the 2023 Form 10-K.

The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation.

The results of operations for the nine months ended October 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2024 or for any other future interim or annual period.

Fiscal Year

Our fiscal year ends on January 31. References to fiscal year 2024, for example, refer to the fiscal year ending January 31, 2024.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition including changes in variable consideration, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Foreign Currency

The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations. For the three months ended October 31, 2023 and 2022, we recognized transaction gains (losses) of $4.3 million and $(0.4) million, respectively. For the nine months ended October 31, 2023 and 2022, we recognized transaction gains (losses) of $2.9 million and $(2.6) million, respectively.

Concentration of Risks

Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable.

We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of October 31, 2023 and January 31, 2023, 93% and 98%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan.

The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints.

With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three and nine months ended October 31, 2023 and 2022, no single customer accounted for 10% or more of our total revenue. As of October 31, 2023, one customer accounted for 12% of our accounts receivable. As of January 31, 2023, no single customer accounted for 10% or more of our accounts receivable.

Stock-Based Compensation

We recognize stock-based compensation expense in accordance with the provisions of Accounting Standards Codification ("ASC") 718, Compensation—Stock Compensation. ASC 718 requires the measurement and recognition of compensation expense for all stock-based awards made to employees, directors, and non-employees based on the grant date fair value of the awards.

The fair value of each stock option is determined using the Black-Scholes pricing model. The fair value of each restricted stock unit ("RSU") and restricted stock award ("RSA") is determined based on the fair value of our Class A common stock on the grant date. The fair value of each performance stock unit ("PSU") that is dependent on the satisfaction of a performance condition is also determined based on the fair value of our Class A common stock on the grant date.The fair value of shares under our employee stock purchase plan ("ESPP") is determined using the Black-Scholes pricing model.

Stock-based compensation expense is included in cost of revenue and operating expenses within our consolidated statements of operations based on the expense classification of the individual earning the award.

The fair value of awards with only service-based vesting conditions is recognized as expense over the requisite service period on a straight-line basis.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

For PSUs dependent on the satisfaction of a performance condition, compensation expense is recognized only when management believes it is probable that the performance condition will be achieved. Although total compensation expense recognized for these awards will ultimately equal the grant date fair value per share multiplied by the number of shares earned by the holder, changes in management's expectations can cause fluctuations in timing of expense over the life of these awards.

The fair value of ESPP shares is recognized over the relevant offering period on a straight-line basis.

With all award types, we account for forfeitures as they occur.

Recently Issued Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

3. Revenue Recognition

Disaggregation of Revenue

The following tables summarize revenue by geographical region (dollars in thousands):


	Three Months Ended October 31,
	2023				2022
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	174,226	53	%	$	147,312	56	%
Europe, Middle East, and Africa	93,782		29	%	65,880		25	%
Asia-Pacific (2)	57,913		18	%	49,552		19	%
Total revenue	$	325,921	100	%	$	262,744	100	%

(1)Revenue from the U.S. represented 48% and 52% of our total revenues for the three months ended October 31, 2023 and 2022, respectively.

(2)Revenue from Japan represented 7% and 7% of our total revenues for the three months ended October 31, 2023 and 2022, respectively.


	Nine Months Ended October 31,
	2023				2022
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	437,396	48	%	$	382,440	51	%
Europe, Middle East, and Africa	271,722		30	%	205,004		27	%
Asia-Pacific (2)	193,701		22	%	162,588		22	%
Total revenue	$	902,819	100	%	$	750,032	100	%

(1)Revenue from the U.S. represented 44% and 47% of our total revenues for the nine months ended October 31, 2023 and 2022, respectively.

(2)Revenue from Japan represented 10% and 10% of our total revenues for the nine months ended October 31, 2023 and 2022, respectively.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Deferred Revenue

During the nine months ended October 31, 2023 and 2022, we recognized $331.1 million and $268.8 million of revenue that was included in the deferred revenue balance as of January 31, 2023 and 2022, respectively.

Remaining Performance Obligations

Our remaining performance obligations are comprised of licenses, subscription services, and professional services and other revenue not yet delivered. As of October 31, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations was $994.6 million, which consists of $538.4 million of billed consideration and $456.2 million of unbilled consideration. We expect to recognize 60% of our remaining performance obligations as revenue over the next 12 months, and the remainder thereafter.

Deferred Contract Acquisition Costs

Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $21.6 million and $16.1 million for the three months ended October 31, 2023 and 2022, respectively, and $52.8 million and $38.0 million for the nine months ended October 31, 2023 and 2022, respectively, and is recorded in sales and marketing expense in the condensed consolidated statements of operations.

4. Marketable Securities

The following is a summary of our marketable securities (in thousands):


	As of October 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	23,853	$	—	$	—	$	23,853
Treasury bills and U.S. government securities	602,927		—		(150)		602,777
Corporate bonds	5,625		—		(14)		5,611
Municipal bonds	1,000		—		(2)		998
Agency bonds	181,054		—		(196)		180,858
Total marketable securities	$	814,459	$	—	$	(362)	$	814,097


	As of January 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	62,470	$	—	$	—	$	62,470
Treasury bills and U.S. government securities (1)	234,848		—		(308)		234,540
Corporate bonds	46,684		—		(198)		46,486
Municipal bonds	6,374		—		(66)		6,308
Agency bonds	7,959		—		(47)		7,912
Total marketable securities	$	358,335	$	—	$	(619)	$	357,716
(1) Treasury bills with both amortized cost and estimated fair value of $10.0 million are included in cash and cash equivalents due to their original maturity of three months or less.

As of October 31, 2023 and January 31, 2023, none and $2.9 million, respectively, of our marketable securities had remaining contractual maturities of one year or more.

As of October 31, 2023 and January 31, 2023, $3.3 million and $3.5 million, respectively, of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of October 31, 2023 and January 31, 2023.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.

5. Fair Value Measurement

The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of October 31, 2023 and January 31, 2023 (in thousands):


	As of October 31, 2023
	Level 1		Level 2		Total

Money market	$	468,683	$	—	$	468,683



Total cash equivalents	468,683		—		468,683
Commercial paper	—		23,853		23,853
Treasury bills and U.S. government securities	602,777		—		602,777
Corporate bonds	—		5,611		5,611
Municipal bonds	—		998		998
Agency bonds	180,858		—		180,858
Total marketable securities	783,635		30,462		814,097
Total	$	1,252,318	$	30,462	$	1,282,780


	As of January 31, 2023
	Level 1		Level 2		Total

Money market	$	319,801	$	—	$	319,801
Treasury bills	9,968		—		9,968
Total cash equivalents	329,769		—		329,769
Commercial paper	—		62,470		62,470
Treasury bills and U.S. government securities	234,540		—		234,540
Corporate bonds	—		46,486		46,486
Municipal bonds	—		6,308		6,308
Agency bonds	7,912		—		7,912
Total marketable securities	242,452		115,264		357,716
Total	$	572,221	$	115,264	$	687,485

Our money market funds, treasury bills and U.S. government securities, and agency bonds are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify commercial paper, corporate bonds, and municipal bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. None of our financial instruments were classified in the Level 3 category as of October 31, 2023 or January 31, 2023.

6. Business Acquisition

Re:infer

On July 29, 2022, we acquired all of the outstanding capital stock of Re:infer LTD. (“Re:infer”), a natural language processing company focused on unstructured documents and communications. Re:infer uses machine learning technology to mine context from communication messages and transform them into actionable data. With this acquisition, we gained technology and an experienced team which we believe will accelerate our technology roadmap, expand the breadth of our current AI-powered automation capabilities, and unlock new automation opportunities for our customers. The Re:infer acquisition was accounted for as a business combination.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following (in thousands):


Cash paid at closing	$	30,117
Fair value of Class A common stock issued at closing (0.2 million shares)	2,965
Loan note paid on July 29, 2023 (first anniversary of closing)	5,863
Loan note to be paid on second anniversary of closing (included in accrued expenses and other current liabilities as of October 31, 2023)	5,570
Working capital adjustment	66
Total	$	44,581

At closing, we also issued an additional 0.4 million shares of Class A common stock to be released to sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to certain employment-related clawback provisions. The aggregate fair value of these shares totaled $7.6 million and is expensed as compensation for post-acquisition services over the three years following the acquisition date.

The following table summarizes the fair values of the assets acquired and liabilities assumed as of the acquisition date (in thousands):


	July 29, 2022
Net tangible assets	$	300
Intangible assets	13,100
Goodwill	34,351
Total assets acquired	47,751
Deferred tax liabilities assumed	(3,170)
Total	$	44,581

The following table sets forth the identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition:


	Fair Value (in thousands)		Estimated Useful Life (in years)
Developed technology	$	10,000	5.0
Customer relationships	3,100		3.0
Total	$	13,100

The acquisition of Re:infer generated goodwill of $34.4 million representing expected synergies and acquired skilled workforce. None of this goodwill is deductible for tax purposes.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

7. Intangible Assets and Goodwill

Intangible Assets, Net

Acquired intangible assets, net consisted of the following as of October 31, 2023 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (in years)
Developed technology	$	28,241	$	(15,206)	$	13,035	3.0
Customer relationships	8,135		(5,577)		2,558		1.4
Trade names and trademarks	271		(257)		14		0.4
Other intangibles	1,231		(378)		853		7.2
Total	$	37,878	$	(21,418)	$	16,460

Acquired intangible assets, net consisted of the following as of January 31, 2023 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (in years)
Developed technology	$	28,517	$	(11,095)	$	17,422	3.5
Customer relationships	8,174		(3,601)		4,573		2.0
Trade names and trademarks	272		(233)		39		1.2
Other intangibles	1,231		(255)		976		7.7
Total	$	38,194	$	(15,184)	$	23,010

We record amortization expense associated with acquired developed technology in cost of licenses revenue and cost of subscription services revenue, trade names and trademarks in sales and marketing expense, customer relationships in sales and marketing expense, and other intangibles in general and administrative expense in the condensed consolidated statements of operations. Amortization of acquired intangible assets for the three months ended October 31, 2023 and 2022 was $2.1 million and $2.1 million, respectively, and for the nine months ended October 31, 2023 and 2022 was $6.4 million and $4.8 million, respectively.

Expected future amortization expense related to intangible assets was as follows as of October 31, 2023 (in thousands):


	Amount
Remainder of year ending January 31, 2024	$	2,123
Year ending January 31,
2025	6,538
2026	4,004
2027	2,369
2028	1,123
Thereafter	303
Total	$	16,460

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Goodwill

Changes in the carrying amount of goodwill during the nine months ended October 31, 2023 were as follows (in thousands):


	Carrying Amount
Balance as of January 31, 2023	$	88,010

Effect of foreign currency translation	(717)
Balance as of October 31, 2023	$	87,293

8. Operating Leases

Our operating leases consist of real estate and vehicles and have remaining lease terms of one year to 14 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that we will exercise those options. Our operating lease arrangements do not contain any material restrictive covenants or residual value guarantees.

Lease costs are presented below (in thousands):


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Operating lease cost	$	3,364	$	3,060	$	9,663	$	8,555
Short-term lease cost	1,225		1,509		3,845		4,552
Variable lease cost	493		362		1,639		885
Sublease income (1)	(426)		(532)		(1,491)		(1,597)
Total	$	4,656	$	4,399	$	13,656	$	12,395

(1) Included in other income (expense), net in the condensed consolidated statements of operations.

The following table represents the weighted-average remaining lease term and discount rate as of the periods presented:


	As of
	October 31, 2023		January 31, 2023
Weighted-average remaining lease term (years)	11.2		12.1
Weighted-average discount rate	7.0	%	7.0	%

Future undiscounted lease payments for our operating lease liabilities as of October 31, 2023 were as follows (in thousands):


	Amount
Remainder of year ending January 31, 2024	$	1,849
Year ending January 31,
2025	12,284
2026	10,173
2027	9,432
2028	8,748
Thereafter	49,931
Total operating lease payments	92,417
Less: imputed interest	(27,825)
Total operating lease liabilities	$	64,592

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

As of October 31, 2023, we had non-cancellable commitments in the amount of $0.5 million related to operating leases of real estate facilities that have not yet commenced.

Current operating lease liabilities of $6.9 million and $7.0 million were included in accrued expenses and other current liabilities on our condensed consolidated balance sheets as of October 31, 2023 and January 31, 2023, respectively.

Supplemental cash flow information related to leases for the three and nine months ended October 31, 2023 and 2022 was as follows (in thousands):


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Cash paid for amounts included in the measurement of operating lease liabilities	$	3,486	$	1,721	$	9,646	$	5,278
Operating lease ROU assets obtained in exchange for new operating lease liabilities	4,139		5,769		8,820		8,659

9. Condensed Consolidated Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of
	October 31, 2023		January 31, 2023
Prepaid expenses and service credits	$	65,755	$	67,794
Other current assets	25,469		26,356
Prepaid expenses and other current assets	$	91,224	$	94,150

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of
	October 31, 2023		January 31, 2023
Computers and equipment	$	28,164	$	28,450
Leasehold improvements	21,860		19,622
Furniture and fixtures	6,751		6,485
Construction in progress	533		2,419
Property and equipment, gross	57,308		56,976
Less: accumulated depreciation	(34,804)		(27,931)
Property and equipment, net	$	22,504	$	29,045

Depreciation expense for the three months ended October 31, 2023 and 2022 was $2.7 million and $2.2 million, respectively. Depreciation expense for the nine months ended October 31, 2023 and 2022 was $8.5 million and $6.0 million, respectively.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	As of
	October 31, 2023		January 31, 2023
Accrued expenses	$	25,079	$	19,411
Withholding tax from employee equity transactions	6,950		3,772
Employee stock purchase plan withholdings	8,217		3,365
Payroll taxes and other benefits payable	6,722		7,644
Income tax payable	12,774		8,750
Value-added taxes payable	4,342		6,381
Operating lease liabilities, current	6,905		6,997
Deferred consideration for business acquisition, current	5,570		5,863
Payable for marketable securities purchase (1)	9,747		3,588
Other	21,708		10,874
Accrued expenses and other current liabilities	$	108,014	$	76,645
(1) Prior period amount has been broken out to conform with current period presentation

10. Credit Facility

On October 30, 2020 we entered into a $200.0 million senior secured revolving credit facility with a maturity date of October 30, 2023 (as subsequently amended, the “Credit Facility”) with HSBC Ventures USA Inc., Silicon Valley Bank, a division of First Citizens Bank & Trust Company (successor by purchase to the FDIC as receiver for Silicon Valley Bridge Bank, N.A. (as successor to Silicon Valley Bank)), Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD (together, the "Lenders"). The Credit Facility contained certain customary covenants, including, but not limited to, those relating to additional indebtedness, liens, asset divestitures, and affiliate transactions.

We did not borrow under the Credit Facility at any time. In September 2023, we and the Lenders terminated the Credit Facility prior to its original maturity date.

11. Commitments and Contingencies

Letters of Credit

We had a total of $3.2 million and $4.3 million in letters of credit outstanding in favor of certain landlords for office space and for credit line facilities as of October 31, 2023 and January 31, 2023, respectively. These letters of credit renew annually and expire on various dates through fiscal year 2025.

Indemnification

In the ordinary course of business, we may provide indemnification of varying scope and terms to customers, vendors, directors, and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties.

These indemnification provisions may survive termination of the underlying agreement and the potential amount of future payments we could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments we could be required to make under these indemnification provisions is indeterminable. As of October 31, 2023 and January 31, 2023, we have not accrued a liability for these indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with these indemnification arrangements was remote.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Restructuring

On June 24, 2022, our board of directors approved restructuring actions to manage our operating expenses by reducing our global workforce by approximately 5%. The workforce reduction aimed to simplify our go-to-market approach and improve sales productivity. In connection with these workforce reductions, we also ceased use of our office in Brooklyn, NY. On November 10, 2022, our board of directors approved further restructuring actions to reduce our global workforce across functions by an additional 6%.

For the nine months ended October 31, 2023, we incurred $2.6 million of expense associated with employee termination benefits in connection our restructuring actions, which were completed during the second quarter of fiscal year 2024.

The following table shows the total amount incurred, and the liability, which is recorded in accrued compensation and employee benefits in the condensed consolidated balance sheets, for restructuring-related employee termination benefits as of October 31, 2023 (in thousands):


	Employee Termination Benefits
Accrued restructuring costs as of January 31, 2023	$	3,889
Restructuring costs incurred during the nine months ended October 31, 2023	2,631
Amount paid during the nine months ended October 31, 2023	(6,072)
Accrued restructuring costs as of October 31, 2023	$	448

Defined Contribution Plans

We sponsor retirement plans for qualifying employees, including a 401(k) plan in the U.S. and defined contribution plans in certain other countries, to which we make matching contributions. Our total matching contributions to all defined contribution plans was $3.3 million and $2.7 million for the three months ended October 31, 2023 and 2022, respectively, and $12.4 million and $11.4 million for the nine months ended October 31, 2023 and 2022, respectively.

Litigation

From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters, which arise in the ordinary course of business. In accordance with ASC 450, Contingencies, we make a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. UiPath and certain of its officers are currently parties to the following litigation matters:

On September 6, 2023, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, Co-CEO Daniel Dines, and CFO Ashim Gupta, captioned Samhita Gera v. UiPath, Inc., et. al. (Case No. 1:23-cv-07908) (the "Securities Action"). The lawsuit asserts claims under Sections 10(b) and 20(a) of the Exchange Act, and alleges that defendants made material misstatements and omissions, including regarding UiPath’s competitive position and its financial results. The complaint is purportedly brought on behalf of a putative class of persons who purchased or otherwise acquired UiPath common stock between April 21, 2021 and March 30, 2022. It seeks unspecified monetary damages, costs and attorneys’ fees, and other unspecified relief as the Court deems appropriate. The proceeding is at a very early stage.

On November 30, 2023, a purported shareholder derivative lawsuit was filed in the United States District Court for the Eastern District of New York against UiPath, as nominal defendant, and Co-CEO Daniel Dines, CFO Ashim Gupta, and several of UiPath’s current and former directors. The case is captioned Polilingua Limited v. Daniel Dines, et al. (Case No. 1:23-cv-08810). The lawsuit alleges that the individual defendants breached their fiduciary duties and committed other alleged misconduct in connection with the statements at issue in the Securities Action and by causing the Company to repurchase shares at inflated prices.The plaintiff seeks unspecified damages and/or restitution on behalf of UiPath, as well as costs and attorneys’ fees, and certain changes to UiPath’s corporate governance and internal controls. The proceeding is at a very early stage.

We have not recorded any accrual related to the aforementioned litigation matters as of October 31, 2023.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Warranty

We warrant to customers that our platform will operate substantially in accordance with its specifications. Historically, no significant costs have been incurred related to product warranties. Based on such historical experience, the probability of incurring such costs in the future is deemed remote. As such, no accruals for product warranty costs have been made.

Non-Cancelable Purchase Obligations

In the normal course of business, we enter into non-cancelable purchase commitments with various parties, mainly for hosting services, software products and services, and credits toward purchase of products and services from strategic alliance partners.

As of October 31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands):


	Amount
Remainder of year ending January 31, 2024	$	11,164
Year ending January 31,
2025	91,225
2026	64,667
2027	21,679
2028	8,245
Thereafter	—
Total	$	196,980

12. Stockholders’ Equity

Stock Repurchase Program

On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. This authorization expires on March 1, 2025, subject to modification by the board of directors in the future.

During the three and nine months ended October 31, 2023, we repurchased 3.2 million shares of our Class A common stock at an average price of $16.26 per share (inclusive of brokerage commission).

Subsequent to October 31, 2023, between November 1, 2023 and November 28, 2023, we repurchased an additional 1.7 million shares of our Class A common stock at an average price of $17.38 per share.

Charitable Donations of Class A Common Stock

We have reserved 2.8 million shares of our Class A common stock to fund our social impact and environmental, social, and governance initiatives. During the nine months ended October 31, 2023, we contributed 0.3 million shares of our Class A common stock to a donor-advised fund in connection with our Pledge 1% commitment. The aggregate fair value of the shares on the contribution date of $4.2 million was recorded within general and administrative expense in the condensed consolidated statements of operations.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Accumulated Other Comprehensive Income (Loss)

For the nine months ended October 31, 2023 and 2022, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands):


	Foreign Currency Translation Adjustments		Unrealized Gain (Loss) on Marketable Securities		Accumulated Other Comprehensive Income (Loss)
Balance as of January 31, 2023	$	8,231	$	(619)	$	7,612
Other comprehensive (loss) income, net of tax	(4,713)		259		(4,454)
Balance as of October 31, 2023	$	3,518	$	(360)	$	3,158


	Foreign Currency Translation Adjustments		Unrealized Gain (Loss) on Marketable Securities		Accumulated Other Comprehensive Income (Loss)
Balance as of January 31, 2022	$	11,234	$	(335)	$	10,899
Other comprehensive loss, net of tax	(3,321)		(625)		(3,946)
Balance as of October 31, 2022	$	7,913	$	(960)	$	6,953

13. Equity Incentive Plans and Stock-Based Compensation

2021 Stock Plan

In April 2021, prior to and in connection with the IPO, we adopted our 2021 Equity Incentive Plan (the "2021 Plan"), which provides for grants of incentive stock options, nonstatutory stock options, stock appreciation rights, RSAs, RSUs, PSUs, and other forms of awards. As of October 31, 2023, we have reserved 173.7 million shares of our Class A common stock to be issued under the 2021 Plan. The number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase.

2021 Employee Stock Purchase Plan

In April 2021, prior to and in connection with the IPO, we adopted our 2021 Employee Stock Purchase Plan (the “ESPP”). As of October 31, 2023, the ESPP authorizes the issuance of 21.5 million shares of our Class A common stock under purchase rights granted to our employees or to employees of any of our designated affiliates. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, by the lesser of (1) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (2) 15.5 million shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth by (1) and (2) above. The ESPP allows participants to purchase shares at the lesser of (a) 85% of the fair market value of our Class A common stock as of the commencement of each offering period, and (b) 85% of the fair market value of our Class A common stock on the corresponding purchase date.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Stock Options

Stock option activity during the nine months ended October 31, 2023 was as follows:


	Stock Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2023	13,898	$	3.32	7.7	$	169,324
Granted	2,763	$	0.10
Exercised	(3,559)	$	1.52
Forfeited	(361)	$	0.51
Outstanding as of October 31, 2023	12,741	$	3.20	7.6	$	158,811

Vested and exercisable as of October 31, 2023	6,252	$	3.68	6.4	$	74,680

The weighted-average grant date fair value of stock options granted during the nine months ended October 31, 2023 was $16.56 per share. The intrinsic value of stock options exercised during the nine months ended October 31, 2023 was $55.4 million.

Unrecognized compensation expense associated with unvested stock options granted and outstanding as of October 31, 2023, was approximately $113.0 million, which is to be recognized over a weighted-average remaining period of 2.3 years.

Restricted Stock Units

RSU activity during the nine months ended October 31, 2023 was as follows:


	RSUs (in thousands)	Weighted-Average Grant Date Fair Value Per Share
Unvested as of January 31, 2023	36,785	$	22.48
Granted	17,615	$	16.54
Vested	(13,773)	$	20.47
Forfeited	(6,569)	$	23.46
Unvested as of October 31, 2023	34,058	$	20.03

The vesting date fair value of RSUs that vested during the nine months ended October 31, 2023 was $236.2 million.

As of October 31, 2023, total unrecognized compensation expense related to unvested RSUs was approximately $612.6 million, which is to be recognized over a weighted-average remaining period of 2.4 years.

Restricted Stock Awards

In September 2020, we issued approximately 0.1 million RSAs to a member of our board of directors at a grant date fair value of $33.22 per share, totaling $4.0 million. Such RSAs vest monthly over four years from the grant date. The unvested shares are subject to a repurchase right held by us. As of October 31, 2023, total unrecognized compensation expense related to unvested RSAs was $0.9 million and will be recognized over the remaining vesting period of 0.9 years.

Performance Stock Units

In July 2023, we granted approximately 0.1 million PSUs at a grant date fair value of $18.08 per share. The PSUs are subject to performance conditions related to the achievement of certain individual and Company targets

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

for fiscal year 2024, and the number of shares earned will ultimately be 0%, 100%, or 200% of the base number of PSUs awarded. To the extent that they are earned, these PSUs will vest on April 1, 2024.

Employee Stock Purchase Plan Awards

During the nine months ended October 31, 2023, 0.8 million shares were purchased under the ESPP at $11.19 per share. As of October 31, 2023, total unrecognized compensation expense related to the ESPP was approximately $0.7 million, which is to be recognized over a weighted-average remaining period of 0.1 years.

Stock-Based Compensation Associated with Business Acquisition

At the closing of the acquisition of Re:infer on July 29, 2022, we issued 0.4 million shares of Class A common stock (outside of the 2021 Plan) to be released to certain employee sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to employment-related clawback provisions. As of October 31, 2023, total unrecognized compensation expense related to these shares was $4.5 million, which is to be recognized over a weighted-average remaining period of 1.8 years.

Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands):


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Cost of subscription services revenue	$	3,791	$	2,844	$	10,778	$	8,901
Cost of professional services and other revenue	2,764		2,557		8,546		8,959
Sales and marketing	37,760		30,763		109,890		117,410
Research and development	30,604		23,435		88,448		73,559
General and administrative	20,961		21,492		65,363		61,968
Total	$	95,880	$	81,091	$	283,025	$	270,797

14. Income Taxes

Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences.

We had a provision for income taxes of $3.9 million, reflecting an effective tax rate of (14.2%), and $1.2 million, reflecting an effective tax rate of (2.1%), for the three months ended October 31, 2023 and 2022, respectively. For the three months ended October 31, 2023 and 2022, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets ("DTAs") for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries.

We had a provision for income taxes of $11.4 million, reflecting an effective tax rate of (10.1%), and $10.1 million, reflecting an effective tax rate of (3.5%), for the nine months ended October 31, 2023 and 2022, respectively. For the nine months ended October 31, 2023 and 2022, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing DTAs for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries.

The realization of tax benefits of net DTAs is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the nine months ended October 31, 2023, we believe it is more likely than not that the tax benefits of DTAs associated with the U.S., Romania, and the U.K. may not be realized. Accordingly, we recorded a full valuation allowance against U.S., Romania, and U.K. DTAs. We intend to maintain each of these full valuation

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

allowances until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance. As of October 31, 2023, there is no valuation allowance recorded against DTAs associated with Japan as we believe it is more likely than not that we will realize such assets during the prescribed statutory period.

As of October 31, 2023, we had gross unrecognized tax benefits totaling $2.3 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $1.5 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. The tax positions of UiPath, Inc. and its subsidiaries are subject to income tax audits in multiple tax jurisdictions globally, with currently open audits in Romania and India, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. At this time, we do not expect any significant changes in the next fiscal quarter based on the current positions undertaken by us.

During the three months ended October 31, 2023, Romania adopted a minimum alternative corporate income tax that is applicable to all companies, including those reporting a net loss, for tax years commencing after January 1, 2024. Given our presence in Romania, we expect this change to increase our effective tax rate and immaterially increase our provision for income taxes for fiscal year 2025.

15. Net Loss Per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts):


	Three Months Ended October 31,
	2023				2022
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(26,951)	$	(4,586)	$	(49,073)	$	(8,651)



Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	484,583		82,453		467,711		82,453
Net loss per share attributable to common stockholders, basic and diluted	$	(0.06)	$	(0.06)	$	(0.10)	$	(0.10)


	Nine Months Ended October 31,
	2023				2022
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(105,657)	$	(18,142)	$	(255,266)	$	(45,397)



Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	480,198		82,453		463,634		82,453
Net loss per share attributable to common stockholders, basic and diluted	$	(0.22)	$	(0.22)	$	(0.55)	$	(0.55)

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands):


	Three Months Ended October 31,
	2023		2022
	Class A	Class B	Class A	Class B

Unvested RSUs	36,911	—	31,022	—
Outstanding stock options	13,207	—	13,812	—
Shares subject to repurchase from RSAs and early exercised stock options	52	—	104	—
Shares issuable under ESPP	714	—	936	—
Returnable shares issued in connection with business acquisition	274	—	427	—
Total	51,158	—	46,301	—


	Nine Months Ended October 31,
	2023		2022
	Class A	Class B	Class A	Class B
Unvested RSUs	38,137	—	29,307	—
Outstanding stock options	13,764	—	13,913	—
Shares subject to repurchase from RSAs and early exercised stock options	56	—	355	—
Shares issuable under ESPP	762	—	851	—
Returnable shares issued in connection with business acquisition	374	—	149	—
Total	53,093	—	44,575	—

16. Related Party Transactions

Beginning in the third quarter of fiscal year 2022, we have at times made use of an aircraft which is owned by Daniel Dines, our Co-Chief Executive Officer, through a special purpose limited liability company and which is operated by a third-party aircraft management company. Mr. Dines, through the special purpose limited liability company, obtained financing for the aircraft and bears all associated operating, personnel, and maintenance costs.

We did not incur any expense related to use of the aircraft for the three and nine months ended October 31, 2023. For the three and nine months ended October 31, 2022, we incurred no expense and $1.9 million of expense, respectively in connection with our business use of the aircraft.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and our audited consolidated financial statements and the related notes and the discussion under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for the fiscal year ended January 31, 2023 included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 24, 2023 (the "2023 Form 10-K"). This discussion, particularly information with respect to our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, includes forward-looking statements that involve risks and uncertainties as described under the heading “Special Note Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q. You should review the disclosure under the heading "Risk Factors" in this Quarterly Report on Form 10-Q and under Part I, Item 1A, "Risk Factors," in the 2023 Form 10-K for discussion of important factors that could cause our actual results to differ materially from those anticipated in these forward-looking statements.

Overview

First established in a Bucharest, Romania apartment in 2005, UiPath was incorporated in Delaware in 2015 as a company principally focused on building and managing automations and developing computer vision technology, which remains the foundation of our platform today. Since that time, we have evolved from our beginnings in RPA into an end-to-end AI-powered automation platform through development and acquisitions, launched new products, and expanded our operations across the globe. Our vision is to enable automation across all knowledge work to accelerate human achievement.

The UiPath Business Automation Platform is The Foundation of Innovation™, providing our customers with a robust set of capabilities that allow them to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale. Our platform enables employees to quickly build automations for both existing and new processes and to utilize software robots to perform a vast array of actions including, but not limited to, logging into applications, extracting information from documents, moving folders, filling in forms, and updating information fields and databases. The ability of our software robots to replicate steps performed by humans in executing business processes drives operational efficiencies and enables companies to deliver on key digital initiatives with greater speed, agility, and accuracy.

Enterprise automation is here, and its momentum is growing as organizations around the world begin to understand the power of automation to drive efficiency and business outcomes. We aspire to be the defining company, advancing the evolution of automation as not just a tool, but as a way of operating and innovating.

Business Highlights for the Three and Nine Months Ended October 31, 2023:

•Quarter-to-date revenue of $325.9 million increased 24% year-over-year.

•Year-to-date revenue of $902.8 million increased 20% year-over-year.

•ARR at October 31, 2023 of $1,378.2 million increased 24% year-over-year.

•Gross margin was 85% for the three months ended October 31, 2023, compared to 84% for the three months ended October 31, 2022.

•Gross margin was 84% for the nine months ended October 31, 2023, compared to 82% for the nine months ended October 31, 2022.

•Cash flow from operations was $153.5 million for the nine months ended October 31, 2023, compared to $(103.9) million for the nine months ended October 31, 2022.

•Cash and cash equivalents, restricted cash, and marketable securities were $1,817.6 million as of October 31, 2023, compared to $1,759.8 million as of January 31, 2023.

The Macroeconomic Environment and Foreign Currency Fluctuations

As a corporation with an international presence, we are subject to risks and uncertainties caused by significant events with macroeconomic impacts, including, but not limited to, the impact of the ongoing Russia-Ukraine conflict or the Israel-Hamas conflict, other changes in geopolitical relationships, rising inflation and interest rates, monetary policy changes, financial services sector instability, and foreign currency fluctuations. Additionally,

Table of Contents

these macroeconomic impacts have generally disrupted the operations of our customers, prospective customers, and partners.

Internationally, we price our platform in currencies that may not be the functional currency. Accordingly, the heightened volatility of global markets has exposed us and will continue to expose us to foreign currency fluctuations, which may impact demand for our platform, our near-term results, comparison of results to prior periods, and our ability to predict future results. Further, cash, cash equivalents, and marketable securities represent a significant portion of our total assets; as such, liquidity concerns in the financial services industry may have an effect on our business, financial conditions, and results of operations. We continuously monitor the direct and indirect impacts of these circumstances on our business and financial results, as well as the overall global economy and geopolitical landscape.

Fiscal Year 2023 Restructuring Actions

On June 24, 2022, our board of directors approved restructuring actions to manage our operating expenses. These actions included an overall reduction of approximately 5% of our global workforce, aimed at simplifying our go-to-market approach to improve market segmentation, increase sales productivity, and provide best-in-class customer experience and outcomes. On November 10, 2022, our board of directors approved further restructuring actions, including an additional 6% workforce reduction to further support our strategic positioning to drive increased execution velocity, operational efficiency, and customer centricity. Restructuring actions were completed during the second quarter of fiscal year 2024. Refer to Note 11, Commitments and Contingencies—Restructuring included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information.

Key Performance Metric

We monitor annualized renewal run-rate ("ARR") to help us measure and evaluate the effectiveness of our operations.

ARR is the key performance metric we use in managing our business because it illustrates our ability to acquire new subscription customers and to maintain and expand our relationships with existing subscription customers. We define ARR as annualized invoiced amounts per solution SKU from subscription licenses and maintenance and support obligations assuming no increases or reductions in customers' subscriptions. ARR does not include the costs we may incur to obtain such subscription licenses or provide such maintenance and support, and does not reflect any actual or anticipated reductions in invoiced value due to contract non-renewals or service cancellations other than for specific reserves, for example those for credit losses or disputed amounts. At October 31, 2023 and 2022, our ARR was $1,378.2 million and $1,110.1 million, respectively, representing a growth rate of 24%. Approximately 18% of this growth rate was due to new customers and 82% of this growth rate was due to existing customers. Our dollar-based net retention rate, which represents the net expansion of ARR from existing customers over the preceding 12 months, was 121% and 126% as of October 31, 2023 and 2022, respectively. We calculate dollar-based net retention rate as of a period end by starting with the ARR from the cohort of all customers as of 12 months prior to such period end ("Prior Period ARR"). We then calculate the ARR from these same customers as of the current period end ("Current Period ARR"). Current Period ARR includes any expansion and is net of contraction or attrition over the last 12 months, but does not include ARR from new customers in the current period. We then divide the total Current Period ARR by the total Prior Period ARR to arrive at the point-in-time dollar-based net retention rate.

Our ARR may fluctuate as a result of a number of factors, including customers’ satisfaction or dissatisfaction with our platform, pricing, competitive offerings, economic conditions, overall changes in our customers’ spending levels, and our ability to successfully execute on our strategic goals. ARR should be viewed independently of revenue and deferred revenue as ARR is an operating metric and is not intended to be combined with or to replace these items. For clarity, we use annualized invoiced amounts per solution SKU rather than revenue calculated in accordance with U.S. GAAP to calculate our ARR. Our invoiced amounts are not matched to transfer of control of the performance obligations associated with the underlying subscription licenses and maintenance and support obligations. This can result in timing differences between our GAAP revenue and ARR calculations. Generally speaking, our ARR calculation simply takes our invoiced amounts per solution SKU under a subscription license or maintenance agreement and divides that amount by the invoice term and multiplies by 365 days to derive the annualized value. In contrast, for our revenue calculated in accordance with GAAP, subscription licenses revenue derived from the sale of term-based licenses hosted on-premises is recognized at the point in time when the customer is able to use and benefit from our software, which is generally upon delivery to the customer or upon the commencement of the renewal term, and maintenance, support, and SaaS revenue is recognized ratably over the term of the arrangement. ARR is not a forecast of future revenue. Unlike ARR, future revenue can be impacted by

Table of Contents

contract start and end dates and duration. The timing of recognition of ARR is determined by contract billing structure, whereas billing structure will neither accelerate nor delay recognition of future revenue. For example, in a multi-year contract invoiced upfront, ARR is the annualized invoiced amount per solution SKU related to the final year of the contract, whereas revenue is determined by total contract value and timing of transfer of the underlying performance obligations. ARR does not include invoiced amounts associated with perpetual licenses or professional services. Investors should not place undue reliance on ARR as an indicator of our future or expected results. Moreover, our presentation of ARR may differ from similarly titled metrics presented by other companies and may not be comparable to such other metrics.

A summary of ARR-related data at October 31, 2023 and 2022 is as follows:


	At October 31,
	2023			2022
	(dollars in thousands)
ARR	$	1,378,152		$	1,110,077
Incremental ARR (1)	268,075			291,671

Customers with ARR ≥ $1 million:
Number of customers	264			201
Percent of current period revenue	49		%	41		%
Customers with ARR ≥ $100 thousand:
Number of customers	1,974			1,711
Percent of current period revenue	84		%	77		%

Dollar-based net retention rate	121		%	126		%
(1) For the twelve months ended October 31, 2023 and 2022, respectively

Components of Results of Operations

Revenue

We derive revenue from the sale of: (1) software licenses for use of our proprietary software and related maintenance and support; (2) the right to access certain software products we host (i.e., SaaS); and (3) professional services.

In fiscal year 2023, we moved toward unifying our commercial offerings for products with both on-premise and cloud deployment options into a single offering that allows customers the choice of either deployment option throughout the term of the contract. These Flex Offerings replaced the hybrid offerings launched in fiscal year 2021. Flex Offerings are comprised of three types of performance obligations: term license, maintenance and support, and SaaS.

Most recently, we have seen an increase in sales of our Flex Offerings compared to sales of our legacy offerings (primarily on-premise solutions sold as term-based licenses bundled with maintenance and support). We expect this trend to continue and, as a result, a greater portion of our revenue will be recognized over time as subscription services revenue rather than as license revenue, which is typically recognized at a point in time.

Licenses

We primarily sell term licenses (including the term license portion of Flex Offerings), which provide customers the right to use software for a specified period of time. Revenue for licenses is recognized at the point in time at which the customer is able to use and benefit from the software, which is generally upon delivery to the customer or upon commencement of the renewal term.

Subscription Services

We generate subscription services revenue through the provision of: (1) maintenance and support services, which include technical support and unspecified updates and upgrades on a when-and-if-available basis for our licenses, and (2) SaaS products, including those sold as part of our Flex Offerings. Maintenance and support and SaaS products represent stand-ready obligations for which revenue is recognized ratably over the term of the arrangements.

Table of Contents

Professional Services and Other

Professional services and other revenue consists of fees associated with professional services for process automation, customer education, and training services. Our professional services contracts are structured on a time and materials or fixed price basis, and the related revenue is recognized as the services are rendered.

Cost of Revenue

Licenses

Cost of licenses revenue consists of all direct costs to deliver our licenses to customers, amortization of software development costs related to our licenses, and amortization of acquired developed technology.

Subscription Services

Cost of subscription services revenue primarily consists of personnel-related expenses of our customer support and technical support teams, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Cost of subscription services revenue also includes third-party consulting services, hosting costs related to our SaaS products, amortization of acquired developed technology and capitalized software development costs related to SaaS products, and allocated overhead. Overhead is allocated to cost of subscription services revenue based on applicable headcount. We recognize these expenses as they are incurred. We expect cost of subscription services revenue to continue to increase in absolute dollars for the foreseeable future as our customer base grows. In the future, we expect further expansion of our cloud-based deployments. As sales of SaaS products become a larger percentage of our total revenue, we expect our gross margin to be impacted by increased hosting fees and cloud infrastructure costs.

Professional Services and Other

Cost of professional services and other revenue primarily consists of personnel-related expenses of our professional services team, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Cost of professional services and other revenue also includes expenses related to third-party consulting services and allocated overhead. We recognize these expenses as they are incurred. We expect cost of professional services and other revenue to increase in absolute dollars in the future as our customer base grows.

Operating Expenses

Our operating expenses consist of sales and marketing, research and development, and general and administrative expenses. Personnel-related expenses are the most significant component of operating expenses and consist of salaries and bonuses, stock-based compensation expense, and employee benefit costs. Operating expenses also include allocated overhead.

Sales and Marketing

Sales and marketing expenses consist primarily of personnel-related expenses associated with our sales and marketing teams and related sales support teams, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Sales and marketing expenses also include sales and partner commissions, marketing event costs, advertising costs, travel, trade shows, other marketing materials, and allocated overhead. We expect that over the longer term our sales and marketing expenses will decrease as a percentage of revenue, although this percentage may fluctuate from period to period due to timing and extent of expenses.

Research and Development

Research and development expenses consist primarily of personnel-related expenses, including salaries and bonuses, stock-based compensation expense, and employee benefits costs for our research and development employees, and allocated overhead. Research and development costs are expensed as incurred, with the exception of certain software development costs which are eligible for capitalization. We expect that our research and development expenses will increase in absolute dollars for the foreseeable future as we continue to invest in efforts to develop new technology and enhance the functionality and capabilities of our existing products and platform infrastructure. Our research and development expenses may fluctuate as a percentage of revenue from period to period due to the timing and extent of expenses.

Table of Contents

General and Administrative

General and administrative expenses consist primarily of personnel-related expenses, including salaries and bonuses, stock-based compensation expense, and employee benefits costs associated with our finance, legal, human resources, compliance, and other administrative teams, as well as accounting and legal professional services fees, other corporate-related expenses, and allocated overhead. We expect that over the longer term our general and administrative expenses will decrease as a percentage of revenue, although this percentage may fluctuate from period to period due to timing and extent of expenses.

Interest Income

Interest income consists of interest income earned on our cash deposits, cash and cash equivalents balances, and marketable securities.

Other Income (Expense), Net

Other income (expense), net primarily consists of foreign exchange gains and losses. Other income (expense), net also includes gains and losses associated with foreign currency forward contracts for those periods in which such contracts were outstanding.

Provision For Income Taxes

Provision for income taxes consists of U.S. federal and state income taxes and income taxes in foreign jurisdictions in which we conduct business. We maintain a full valuation allowance on our U.S. federal and state, Romanian, and U.K. DTAs, as we have concluded that it is more likely than not that these DTAs will not be realized. Our effective tax rate is affected by tax rates in foreign jurisdictions and the relative amounts of income we earn in those jurisdictions, as well as by non-deductible expenses as permanent differences and by changes in our valuation allowances.

Table of Contents

Results of Operations

The following tables set forth selected condensed consolidated statement of operations data and such data as a percentage of total revenue for each of the periods indicated:


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
	(in thousands)				(in thousands)
Revenue:
Licenses	$	148,068	$	118,175	$	401,407	$	338,875
Subscription services	167,529		130,159		473,880		370,309
Professional services and other	10,324		14,410		27,532		40,848
Total revenue	325,921		262,744		902,819		750,032
Cost of revenue:
Licenses (1)	2,781		3,208		8,336		7,915
Subscription services (1)(2)(3)(4)	28,647		20,578		78,502		63,949
Professional services and other (2)(3)(4)	18,492		18,982		55,736		60,496
Total cost of revenue	49,920		42,768		142,574		132,360
Gross profit	276,001		219,976		760,245		617,672
Operating expenses:
Sales and marketing (1)(2)(3)(4)	191,282		156,469		521,413		527,798
Research and development (2)(3)(4)	84,514		67,341		246,462		203,880
General and administrative (1)(2)(3)(4)	56,024		63,157		172,185		189,130
Total operating expenses	331,820		286,967		940,060		920,808
Operating loss	(55,819)		(66,991)		(179,815)		(303,136)
Interest income	14,483		9,561		41,913		15,057
Other income (expense), net	13,725		888		25,491		(2,523)
Loss before income taxes	(27,611)		(56,542)		(112,411)		(290,602)
Provision for income taxes	3,926		1,182		11,388		10,061
Net loss	$	(31,537)	$	(57,724)	$	(123,799)	$	(300,663)

(1) Includes amortization of acquired intangible assets as follows:
Cost of licenses revenue	$	836	$	777	$	2,523	$	1,935
Cost of subscription services revenue	589		570		1,767		1,230
Sales and marketing	675		659		2,027		1,486
General and administrative	41		44		123		136
Total amortization of acquired intangible assets	$	2,141	$	2,050	$	6,440	$	4,787

(2) Includes stock-based compensation expense as follows:
Cost of subscription services revenue	$	3,791	$	2,844	$	10,778	$	8,901
Cost of professional services and other revenue	2,764		2,557		8,546		8,959
Sales and marketing	37,760		30,763		109,890		117,410
Research and development	30,604		23,435		88,448		73,559
General and administrative	20,961		21,492		65,363		61,968
Total stock-based compensation expense	$	95,880	$	81,091	$	283,025	$	270,797

(3) Includes employer payroll tax expense related to equity transactions as follows:
Cost of subscription services revenue	$	58	$	34	$	233	$	180
Cost of professional services and other revenue	42		26		181		167
Sales and marketing	625		416		2,350		3,045
Research and development	387		170		1,572		971
General and administrative	340		123		1,209		486
Total employer payroll tax expense related to equity transactions	$	1,452	$	769	$	5,545	$	4,849

(4) Includes restructuring expense as follows:
Cost of subscription services revenue	$	(53)	$	—	$	114	$	137
Cost of professional services and other revenue	—		—		—		320
Sales and marketing	65		511		1,381		11,243
Research and development	(7)		—		387		43
General and administrative	20		580		749		1,382
Total restructuring expense	$	25	$	1,091	$	2,631	$	13,125

Table of Contents


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
	(as a percentage of revenue)				(as a percentage of revenue)
Revenue:
Licenses	46	%	45	%	44	%	45	%
Subscription services	51	%	50	%	53	%	49	%
Professional services and other	3	%	5	%	3	%	6	%
Total revenue	100	%	100	%	100	%	100	%
Cost of revenue:
Licenses	1	%	1	%	1	%	1	%
Subscription services	9	%	8	%	9	%	9	%
Professional services and other	5	%	7	%	6	%	8	%
Total cost of revenue	15	%	16	%	16	%	18	%
Gross profit	85	%	84	%	84	%	82	%
Operating expenses:
Sales and marketing	59	%	60	%	58	%	70	%
Research and development	26	%	25	%	27	%	27	%
General and administrative	17	%	24	%	19	%	25	%
Total operating expenses	102	%	109	%	104	%	122	%
Operating loss	(17)	%	(25)	%	(20)	%	(40)	%
Interest income	4	%	3	%	5	%	2	%
Other income (expense), net	4	%	—	%	3	%	—	%
Loss before income taxes	(9)	%	(22)	%	(12)	%	(38)	%
Provision for income taxes	1	%	—	%	2	%	2	%
Net loss	(10)	%	(22)	%	(14)	%	(40)	%

Table of Contents

Comparison of the Three Months Ended October 31, 2023 and 2022

Revenue


	Three Months Ended October 31,
	2023		2022		Change		Change %
	(dollars in thousands)
Licenses	$	148,068	$	118,175	$	29,893	25	%
Subscription services	167,529		130,159		37,370		29	%
Professional services and other	10,324		14,410		(4,086)		(28)	%
Total revenue	$	325,921	$	262,744	$	63,177	24	%

Total revenue increased by $63.2 million, or 24%, for the three months ended October 31, 2023 compared to the three months ended October 31, 2022, due to a $37.4 million increase in subscription services revenue and a $29.9 million increase in licenses revenue, partially offset by a $4.1 million decrease in professional services and other revenue. As we continued to expand our sales efforts in the U.S. and internationally, total revenue grew across all regions. Of the growth in total revenue, 19% was attributable to new customers and 81% was attributable to existing customers. Subscription services revenue is recognized ratably over the subscription term; therefore, the increase in subscription services revenue is driven both by sales in prior periods for which we continue to provide maintenance and support and SaaS and by new sales in the current period.

Cost of Revenue and Gross Margin


	Three Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Licenses	$	2,781		$	3,208		$	(427)	(13)	%
Subscription services	28,647			20,578			8,069		39	%
Professional services and other	18,492			18,982			(490)		(3)	%
Total cost of revenue	$	49,920		$	42,768		$	7,152	17	%
Gross margin	85		%	84		%

Total cost of revenue increased by $7.2 million, or 17%, for the three months ended October 31, 2023 compared to the three months ended October 31, 2022, primarily due to an increase in cost of subscription services revenue. The increase in cost of subscription services revenue was driven by a $4.0 million increase in personnel-related expenses, which included a $2.6 million increase in salary-related and bonus expenses associated with both increased headcount and merit increases, and a $0.9 million increase in stock-based compensation expense. Cost of subscription services revenue was also impacted by a $2.3 million increase in hosting costs and software services due to increased usage and a $1.2 million increase in costs associated with the use of third-party vendors. The decrease in cost of licenses revenue was driven by a $0.4 million decrease in software services costs. The decrease in cost of professional services and other revenue was driven by a $0.5 million decrease in costs associated with the use of third-party vendors to deliver professional services to our customers.

Our gross margin increased to 85% for the three months ended October 31, 2023 compared to 84% for the three months ended October 31, 2022 due to growth in higher-margin subscription services and licenses revenue and decrease in lower-margin professional services and other revenue.

Operating Expenses

Sales and Marketing


	Three Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Sales and marketing	$	191,282		$	156,469		$	34,813	22	%
Percentage of revenue	59		%	60		%

Table of Contents

Sales and marketing expense increased by $34.8 million, or 22%, for the three months ended October 31, 2023 compared to the three months ended October 31, 2022. The increase was primarily attributable to a $12.9 million increase in sales commissions expense as a result of higher commissions earned and higher amortization of capitalized contract acquisition costs, and an $11.3 million increase in personnel-related expenses, which included a $7.0 million increase in stock-based compensation expense, a $3.2 million increase in salary-related and bonus expenses, and a $1.0 million increase in employee insurance costs. Sales and marketing expense was also impacted by a $3.3 million increase in marketing event costs, largely related to our Forward VI event, and a $3.0 million increase in sales-related software expenses.

Research and Development


	Three Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Research and development	$	84,514		$	67,341		$	17,173	26	%
Percentage of revenue	26		%	25		%

Research and development expense increased by $17.2 million, or 26%, for the three months ended October 31, 2023 compared to the three months ended October 31, 2022. The increase was primarily attributable to a $12.8 million increase in personnel-related expenses, which included a $7.2 million increase in stock-compensation expense and a $4.6 million increase in salary-related and bonus expenses associated with both increased headcount and merit increases. Research and development expense was also impacted by a $4.3 million increase in hosting and software service expenses, a $0.6 million increase in depreciation expense, and a $0.4 million increase in travel expenses, partially offset by a $0.9 million decrease in third-party consulting fees.

General and Administrative


	Three Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
General and administrative	$	56,024		$	63,157		$	(7,133)	(11)	%
Percentage of revenue	17		%	24		%

General and administrative expense decreased by $7.1 million, or 11%, for the three months ended October 31, 2023 compared to the three months ended October 31, 2022. The decrease was primarily attributable to a $2.0 million decrease in personnel-related expenses, which included an $0.8 million decrease in salary-related and bonus expenses driven by decreased headcount following the completion of our fiscal year 2023 restructuring actions, a $0.6 million decrease in employee termination benefits related to the completion those actions, and a $0.5 million decrease in stock-based compensation expense. General and administrative expense was also impacted by a $2.1 million decrease in third-party consulting fees, a $1.5 million decrease in insurance costs, a $0.7 million decrease in our provision for credit losses, and a $0.6 million decrease in depreciation expense.

Interest Income


	Three Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Interest income	$	14,483		$	9,561		$	4,922	51	%
Percentage of revenue	4		%	3		%

Interest income increased by $4.9 million, or 51%, for the three months ended October 31, 2023 compared to the three months ended October 31, 2022 as a result of a period-over-period increase in our marketable securities balance as well as increased interest rates.

Table of Contents

Other Income (Expense), Net


	Three Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Other income (expense), net	$	13,725		$	888		$	12,837	NM (1)
Percentage of revenue	4		%	—		%
(1) Not meaningful

Other income (expense), net increased by $12.8 million for the three months ended October 31, 2023 compared to the three months ended October 31, 2022, primarily due to an $8.5 million increase in amortization of discounts on marketable securities and a $4.7 million increase in gains from foreign currency transactions.

Provision For Income Taxes


	Three Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Provision for income taxes	$	3,926		$	1,182		$	2,744	232	%
Percentage of revenue	1		%	—		%

Provision for income taxes increased by $2.7 million, or 232%, for the three months ended October 31, 2023 compared to the three months ended October 31, 2022. The increase in provision for income taxes was primarily driven by higher foreign tax expenses in the current period than in the prior comparable period for our cost-plus entities in certain foreign jurisdictions.

Comparison of the Nine Months Ended October 31, 2023 and 2022

Revenue


	Nine Months Ended October 31,
	2023		2022		Change		Change %
	(dollars in thousands)
Licenses	$	401,407	$	338,875	$	62,532	18	%
Subscription services	473,880		370,309		103,571		28	%
Professional services and other	27,532		40,848		(13,316)		(33)	%
Total revenue	$	902,819	$	750,032	$	152,787	20	%

Total revenue increased by $152.8 million, or 20%, for the nine months ended October 31, 2023 compared to the nine months ended October 31, 2022, due to a $103.6 million increase in subscription services revenue, related in part to the transition to our Flex Offerings, and a $62.5 million increase in licenses revenue, partially offset by a $13.3 million decrease in professional services and other revenue. As we continued to expand our sales efforts in the U.S. and internationally, total revenue grew across all regions. Of the increase in total revenue, 19% was attributable to new customers and 81% was attributable to existing customers.

Cost of Revenue and Gross Margin


	Nine Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Licenses	$	8,336		$	7,915		$	421	5	%
Subscription services	78,502			63,949			14,553		23	%
Professional services and other	55,736			60,496			(4,760)		(8)	%
Total cost of revenue	$	142,574		$	132,360		$	10,214	8	%
Gross margin	84		%	82		%

Table of Contents

Total cost of revenue increased by $10.2 million, or 8%, for the nine months ended October 31, 2023 compared to the nine months ended October 31, 2022, primarily due to an increase in cost of subscription services revenue, partially offset by a decrease in cost of professional services and other revenue. The increase in cost of subscription services revenue was primarily driven by an $8.8 million increase in personnel-related expenses, which included a $5.7 million increase in salary-related and bonus expenses associated with both increased headcount and merit increases, a $1.9 million increase in stock-based compensation expense, and a $1.0 million increase in employee insurance costs. Cost of subscription services revenue was also impacted by a $3.2 million increase in hosting and software services costs as a result of increased usage, a $1.2 million increase in costs associated with the use of third-party vendors, and an aggregate $0.8 million increase in depreciation and amortization expense and other administrative costs. The increase in cost of licenses revenue was primarily driven by a $0.6 million increase in depreciation and amortization expense. The decrease in cost of professional services and other revenue was primarily driven by a $4.3 million decrease in costs associated with the use of third-party vendors to deliver professional services to our customers. Additionally, cost of professional services and other revenue was impacted by a $1.2 million decrease in personnel-related expenses, primarily related to lower bonus expenses and stock-based compensation expense, partially offset by an aggregate $0.8 million increase in software services and travel expenses.

Our gross margin increased to 84% for the nine months ended October 31, 2023 compared to 82% for the nine months ended October 31, 2022 due to growth in higher-margin subscription services revenue and decrease in lower-margin professional services and other revenue.

Operating Expenses

Sales and Marketing


	Nine Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Sales and marketing	$	521,413		$	527,798		$	(6,385)	(1)	%
Percentage of revenue	58		%	70		%

Sales and marketing expense decreased by $6.4 million, or 1%, for the nine months ended October 31, 2023 compared to the nine months ended October 31, 2022. This decrease was primarily attributable to a $35.6 million decrease in personnel-related expenses, which included a $15.0 million decrease in salary-related and bonus expenses as a result of a decreased headcount driven by our fiscal year 2023 restructuring actions, a $9.4 million decrease in employee termination benefits resulting from the completion of those actions during the second quarter of fiscal 2024, a $7.5 million decrease in stock-based compensation expense, a $1.8 million decrease in employer payroll taxes, and a $1.1 million decrease in general severance expense. Sales and marketing expense was also impacted by a $4.2 million decrease in third-party consulting fees and a $1.6 million decrease related to a non-recurring abandonment and impairment charge associated with the early termination of a leased office space incurred during the first quarter of fiscal year 2023. These decreases were partially offset by a $17.1 million increase in sales commissions expense as a result of higher amortization of capitalized contract acquisition costs, a $9.2 million increase in hosting and software service costs, a $6.6 million increase in marketing and travel expenses due in part to our Forward VI event, and an aggregate $1.7 million increase in depreciation and amortization expense and other administrative costs.

Research and Development


	Nine Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Research and development	$	246,462		$	203,880		$	42,582	21	%
Percentage of revenue	27		%	27		%

Research and development expense increased by $42.6 million, or 21%, for the nine months ended October 31, 2023 compared to the nine months ended October 31, 2022. The increase was primarily attributable to a $32.0 million increase in personnel-related expenses, which included a $14.9 million increase in stock-based compensation expense, a $13.5 million increase in salary-related and bonus expenses associated with both increased headcount and merit increases, a $1.6 million increase in employee insurance costs, and a $0.9 million

Table of Contents

increase in general employee severance. Research and development expense was also impacted by a $5.9 million increase in hosting costs, a $3.2 million increase in research and development-related software expenses, a $1.8 million increase in travel expenses, a $0.8 million increase in depreciation expense, and a $0.8 million increase in rent and facility-related costs, partially offset by a $1.7 million decrease in third-party consulting fees.

General and Administrative


	Nine Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
General and administrative	$	172,185		$	189,130		$	(16,945)	(9)	%
Percentage of revenue	19		%	25		%

General and administrative expense decreased by $16.9 million, or 9%, for the nine months ended October 31, 2023 compared to the nine months ended October 31, 2022. This decrease was primarily attributable to a $6.3 million decrease in third-party consulting fees, a $3.2 million decrease in software service expenses, and $3.0 million decrease in insurance costs. General and administrative expense was also impacted by a $2.2 million decrease in credit loss expense primarily associated with customers in Russia impacting collections during the first quarter of fiscal year 2023, a $2.1 million decrease in charitable donations mainly driven by a smaller contribution of Class A common shares to a donor-advised fund in the current year, and a $1.1 million decrease in travel expenses. These decreases were partially offset by a $1.4 million increase in rent and facility-related costs.

Interest Income


	Nine Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Interest income	$	41,913		$	15,057		$	26,856	178	%
Percentage of revenue	5		%	2		%

Interest income increased by $26.9 million, or 178%, for the nine months ended October 31, 2023 compared to the nine months ended October 31, 2022 as a result of a period-over-period increase in our marketable securities balance as well as increased interest rates.

Other Income (Expense), Net


	Nine Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Other income (expense), net	$	25,491		$	(2,523)		$	28,014	NM (1)
Percentage of revenue	3		%	—		%
(1) Not meaningful

Other income (expense), net increased by $28.0 million for the nine months ended October 31, 2023 compared to the nine months ended October 31, 2022, primarily due to a $20.1 million increase in amortization of discounts on marketable securities and a $5.5 million increase in gains from foreign currency transactions.

Provision For Income Taxes


	Nine Months Ended October 31,
	2023			2022			Change		Change %
	(dollars in thousands)
Provision for income taxes	$	11,388		$	10,061		$	1,327	13	%
Percentage of revenue	2		%	2		%

Provision for income taxes increased by $1.3 million, or 13%, for the nine months ended October 31, 2023 compared to the nine months ended October 31, 2022. The increase in provision for income taxes was primarily

Table of Contents

driven by higher foreign tax expenses in the current period than in the prior comparable period for our cost-plus entities in certain foreign jurisdictions.

Liquidity and Capital Resources

We have financed operations since our inception primarily through customer payments and net proceeds from issuance of equity securities. Our principal uses of cash in recent periods have been to fund our operations, invest in capital expenditures, engage in various business acquisitions, and, more recently, stock repurchases. As of October 31, 2023, our principal sources of liquidity were cash and cash equivalents, restricted cash, and marketable securities totaling $1,817.6 million, and we had an accumulated deficit of $1,948.1 million. During the nine months ended October 31, 2023, we reported a net loss of $123.8 million and net cash provided by operating activities of $153.5 million.

Our future capital requirements will depend on many factors, including our revenue growth rate, sales of our products and services, license renewal activity, the timing and the amount of cash received from customers, the expansion of sales and marketing activities, the timing and extent of spending to support development efforts, the introduction of new and enhanced products, the continuing market adoption of our products, expenses associated with our international expansion, the timing and extent of capital expenditures to invest in existing and new office spaces, and the timing and extent of stock repurchases. We may in the future enter into arrangements to acquire or invest in complementary businesses, products, and technologies. We may be required to seek additional equity or debt financing. In the event that we require additional financing, we may not be able to raise such financing on terms acceptable to us or at all. If we are unable to raise additional capital or generate cash flows necessary to expand our operations and invest in continued innovation, we may not be able to compete successfully, which would harm our business, operations and financial condition.

We believe that our existing cash and cash equivalents, restricted cash, marketable securities, and payments from customers will be sufficient to fund our anticipated cash requirements for the next twelve months and the long term.

Credit Facility

In October 2020, we entered into the Credit Facility. We did not borrow under the Credit Facility at any time, and it was terminated in September 2023 prior to its scheduled maturity date. Refer to Note 10, Credit Facility for further details.

Stock Repurchase Program

Cash Flows

The following table summarizes our cash flows for the periods presented:


	Nine Months Ended October 31,
	2023		2022
	(in thousands)
Net cash provided by (used in) operating activities (1)	$	153,480	$	(103,938)
Net cash used in investing activities	$	(430,930)	$	(162,676)
Net cash used in financing activities	$	(114,978)	$	(43,795)

(1) Inclusive of:
Cash paid for employer payroll taxes related to employee equity transactions	$	(6,183)	$	(6,399)
Net payments of employee tax withholdings on stock option exercises	$	(788)	$	(6,370)
Cash paid for restructuring costs	$	(6,072)	$	(11,585)

Table of Contents

Operating Activities

Our largest source of operating cash is cash generation from sales to our customers. Our primary uses of cash from operating activities are for personnel-related expenses, direct costs to deliver licenses and provide subscription and professional services, and marketing expenses. To date, our operating cash flows have generally been negative and we have supplemented working capital requirements primarily through net proceeds from the sale of equity securities.

Net cash provided by operating activities for the nine months ended October 31, 2023 of $153.5 million was driven by cash collections from our customers, which were approximately 23% higher than during the nine months ended October 31, 2022. These cash inflows were partially offset by cash payments for operating expenditures, primarily associated with the compensation of our teams, including fiscal year 2023 annual bonuses paid in the first quarter of fiscal year 2024. Other cash operating expenditures included payments related to our fiscal year 2023 workforce restructuring which was concluded during the second quarter of fiscal year 2024, and payments for professional services, software, and office rent.

Net cash used in operating activities for the nine months ended October 31, 2022 of $103.9 million was driven by cash payments for operating expenditures, primarily associated with the compensation of our teams, including annual bonuses paid in the first quarter of fiscal year 2023. Other cash operating expenditures included payments related to our workforce restructuring, professional services, software, and office rent. These outflows were partially offset by cash collections from our customers.

Investing Activities

Net cash used in investing activities for the nine months ended October 31, 2023 of $430.9 million was primarily driven by $1,006.6 million in purchases of marketable securities partially offset by $576.5 million in maturities of marketable securities.

Net cash used in investing activities for the nine months ended October 31, 2022 of $162.7 million was primarily driven by $204.3 million in purchases of marketable securities, $29.5 million in cash consideration associated with the acquisition of Re:infer, which is presented net of cash acquired, and $21.6 million in capital expenditures, partially offset by $93.3 million in maturities of marketable securities.

Financing Activities

Net cash used in financing activities for the nine months ended October 31, 2023 of $115.0 million was driven by payments of tax withholdings on net settlement of equity awards of $75.5 million, $52.6 million in repurchases of Class A common stock under our stock repurchase program, and $5.9 million loan note payment on the first anniversary of the acquisition of Re:infer, partially offset by proceeds from employee stock purchase plan contributions of $14.3 million and stock option exercise proceeds of $5.4 million.

Net cash used in financing activities for the nine months ended October 31, 2022 of $43.8 million was driven by payments of tax withholdings on net settlement of equity awards of $53.3 million, net payments of tax withholdings on sell-to-cover equity award transactions of $10.1 million, and $1.5 million in repurchases of unvested early exercised stock options, partially offset by proceeds from employee stock purchase plan contributions of $13.5 million and stock option exercise proceeds of $7.6 million.

Material Cash Requirements

See Note 11, Commitments and Contingencies—Non-Cancelable Purchase Obligations, for further details on the timing of our purchase commitments. There were no other significant changes to our material cash requirements during the nine months ended October 31, 2023 from the contractual obligations disclosed in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” set forth in the 2023 Form 10-K.

Critical Accounting Estimates

There have been no material changes to our critical accounting estimates as compared to those disclosed in the 2023 Form 10-K.

Table of Contents

Recent Accounting Pronouncements

See Note 2 , Summary of Significant Accounting Policies —Recently Issued Accounting Pronouncements, included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are exposed to market risk in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is principally the result of fluctuations in interest rates and foreign currency exchange rates.

Interest Rate Risk

As of October 31, 2023, we had $1,003.1 million of cash and cash equivalents. Cash and cash equivalents consist of cash in banks, bank deposits, and money market accounts. In addition, we had $814.1 million of marketable securities, consisting of corporate bonds, commercial paper, municipal bonds, agency bonds, and treasury bills and U.S. government securities. Such interest-earning instruments carry a degree of interest rate risk. The primary objectives of our investment activities are the preservation of capital, the fulfillment of liquidity needs, and the fiduciary control of cash. We do not enter into investments for trading or speculative purposes. The effect of a hypothetical 10% change in interest rates would not have had a material impact on our condensed consolidated financial statements for the nine months ended October 31, 2023.

Foreign Currency Exchange Risk

The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while translation of revenue and expenses is based upon average monthly rates. Translation adjustments are recorded as a component of accumulated other comprehensive income, and transaction gains and losses are recorded in other income (expense), net on our condensed consolidated financial statements. The estimated translation impact to our condensed consolidated financial statements of a hypothetical 10% change in foreign currency exchange rates would amount to $11.7 million for the nine months ended October 31, 2023. During the nine months ended October 31, 2023, approximately 53% of our revenues and approximately 34% of our expenses were denominated in non-U.S. dollar currencies. For the nine months ended October 31, 2023 we recognized net foreign currency transaction gains of $2.9 million.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. In addition, they are designed to ensure that such information is accumulated and communicated to our management, including our Co-Chief Executive Officers ("Co-CEOs") and Chief Financial Officer ("CFO") as appropriate to allow timely decisions regarding required disclosure.

Pursuant to in Rules 13(a)-13(e) and 15(d)-15(e) under the Exchange Act, our management, with the participation of our Co-CEOs and CFO, performed an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Co-CEOs and CFO concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of October 31, 2023.

Changes in Internal Control Over Financial Reporting

During the three months ended October 31, 2023, no change in internal control over financial reporting was identified in connection with the evaluation required by Rule 13a-15(d) and Rule 15d-15(d) of the Exchange Act that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

Our management, including our Co-CEOs and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at a reasonable assurance level. However, any control system, no matter how well designed and

Table of Contents

operated, can only provide reasonable, not absolute, assurance that its objectives will be met. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures and internal control over financial reporting, including resource constraints, errors in judgment, and the possibility that controls and procedures will be circumvented by collusion, by management override, or by mistake. Additionally, the design of any control system is based in part on management assumptions about the likelihood of future events, and there can be no assurance that the system will succeed in achieving its objectives under all potential future scenarios. As a result of these limitations, our management does not expect that our disclosure controls and procedures and internal control over financial reporting will prevent all potential errors or fraud or detect all potential misstatements due to error or fraud.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

Refer to Note 11, Commitments and Contingencies—Litigation, to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for a description of current legal proceedings.

Item 1A. Risk Factors.

Our operations and financial results are subject to various risks and uncertainties, some of which are beyond our control. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risks discussed in the 2023 Form 10-K, including the disclosure under Part I, Item 1A, "Risk Factors,” which are risks we believe could materially affect our business, financial condition and future results. These are not the only risks we face. Other risks and uncertainties we are not currently aware of or that we currently consider immaterial also may materially adversely affect our business, financial condition and future results. Risks we have identified but currently consider immaterial could still materially adversely affect our business, financial condition and future results if our assumptions about those risks are incorrect or if circumstances change.

There have been no material changes to the risk factors previously disclosed in Part I, Item 1A of the 2023 Form 10-K, except as follows:

If we are not able to introduce and release new features or services successfully and to make enhancements to our platform or products, our business and results of operations could be adversely affected.

Our ability to attract new customers and increase revenue from existing customers depends in part on our ability to enhance and improve our platform and to introduce new features and services. To grow our business and remain competitive, we must continue to enhance our platform with features that reflect the constantly evolving nature of automation and artificial intelligence ("AI") technology and our customers’ evolving needs. For instance, with the development of next-generation solutions that utilize new and advanced features, including AI and machine learning, we may be required to commit significant resources to developing new products, enhancements and developments. Other companies may incorporate AI into their products more quickly or more successfully than us, which could impair our ability to compete effectively and adversely affect our financial results. The success of new products, enhancements, and developments depends on several factors including, but not limited to: our anticipation of market changes and demands for product features, successful product design and timely release of new functionality, sufficient customer demand, cost effectiveness in our product development efforts, and the proliferation of new technologies that are able to deliver competitive products and services at lower prices, more efficiently, more conveniently, or more securely. In addition, because our platform is designed to operate with a variety of systems, applications, data, and devices, we will need to continuously modify and enhance our platform to keep pace with changes in such systems. We may not be successful in developing these modifications and enhancements. Furthermore, the addition of features and solutions to our platform will increase our research and development expenses. Any new features that we develop may not be introduced in a timely or cost-effective manner or may not achieve the market acceptance necessary to generate sufficient revenue to justify the related expenses. It is difficult to predict customer adoption of new features. Such uncertainty limits our ability to forecast our future results of operations and subjects us to a number of challenges, including our ability to plan for and model future growth. If we cannot address such uncertainties and successfully develop new features, enhance our software, or otherwise overcome technological challenges and competing technologies, our business and results of operations could be adversely affected. In addition, significant delays between announcement and general availability of new functionality could adversely affect our business.

We also offer professional services including consulting and training and must continually adapt to assist our customers in deploying our platform in accordance with their specific automation strategies. If we cannot introduce new services or enhance our existing services to keep pace with changes in our customers’ deployment strategies, we may not be able to attract new customers, retain existing customers, and expand their use of our software or secure renewal contracts, which are important for the future of our business.

Issues raised by the use of AI (including machine learning and large language models) in our platforms may result in reputational harm or liability.

AI is enabled by or integrated into parts of our technology platform and has been and is a significant and growing element of our business. As with many developing technologies, AI presents risks and challenges that

Table of Contents

could affect its further development, adoption, and use, and therefore our business. AI algorithms and models may be flawed. Datasets in AI training, development, or operations may be insufficient, of poor quality, reflect unwanted forms of bias, or raise other legal concerns (such as concerns regarding copyright protections or data protection). Inappropriate or controversial data practices by, or practices reflecting inherent biases of, data scientists, engineers, and end-users of our systems could impair the acceptance of AI solutions. Third-party AI capabilities that can be integrated with our platform, including generative artificial intelligence, could also produce false or “hallucinatory” inferences about customer data or enterprises, or other information or subject matter, or could raise the risks brought by their inherent flawed security or data practices. The use of generative AI processes at scale is relatively new, and may lead to challenges, concerns, and risks that are significant or that we may not be able to predict, especially if our use of these technologies in our products and services were to become more important to us over time. If the recommendations, forecasts, or analyses that AI applications assist in producing are deficient or inaccurate, we could be subject to competitive harm, potential legal liability, including under existing legislation or forthcoming and new proposed legislation regulating AI in jurisdictions such as the EU, and brand or reputational harm. The rapid evolution of AI may also require additional resources to develop, test, and maintain our platforms and products to help ensure that AI is implemented appropriately in order to minimize unintended or harmful impact, which may be costly and may not produce the benefits and results that we expect.

Some AI scenarios present ethical issues, and the enablement or integration of AI into our platform may subject us to new or heightened legal, regulatory, ethical, or other challenges. Our technologies and business practices are designed to mitigate many of these risks. For example, our platform includes data governance tools and other tools which help to regulate and limit user access to data sets and develop, deploy, and manage more effective and responsible AI capabilities. In addition, we have developed internal responsible AI guidelines. However, there is still work to implement these controls and if these controls are not properly implemented by, or for, our customers, or if we enable or offer AI solutions that are controversial or problematic because of their purported or real impact on human rights, privacy, employment, or other societal issues, we may experience brand or reputational harm, as well as regulatory or legal scrutiny.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Recent Sales of Unregistered Equity Securities

None.

Use of Proceeds from Initial Public Offering of Class A Common Stock

In April 2021, we completed our IPO, in which we issued and sold 13.0 million shares of our Class A common stock, including 3.6 million shares pursuant to the exercise in full of the underwriters’ option to purchase additional shares, and the selling stockholders sold an additional 14.5 million shares, at a public offering price of $56.00 per share, resulting in net proceeds to us of $687.9 million after deducting underwriting discounts and commissions and offering expenses. We did not receive any proceeds from the sale of shares by the selling stockholders. All of the shares issued and sold in the IPO were registered under the Securities Act pursuant to a registration statement on Form S-1 (File No. 333-254738), which was declared effective by the SEC on April 20, 2021. There has been no material change in the planned uses of proceeds from our IPO from those disclosed in the 2023 Form 10-K.

Issuer Purchase of Equity Securities

The following table presents our Class A common stock repurchase activity under our previously announced stock repurchase program for the three months ended October 31, 2023 (in thousands, except for per share data):


Period	Total Number of Shares Purchased	Average Price Paid Per Share (1)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
August 1 – 31	—	$	—	—	$	—
September 1 – 30	592	$	16.89	592	$	490,005
October 1 – 31	2,647	$	16.09	2,647	$	447,416
Total	3,239			3,239

(1) Excludes brokerage commission.

(2) On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Repurchases under the program may be effected through open

Table of Contents

market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. This authorization expires on March 1, 2025, subject to modification by the board of directors in the future. As part of this stock repurchase program, On October 12, 2023, UiPath, Inc. adopted a non-discretionary stock repurchase agreement intended to satisfy Rule 10b5-1, covering the period between October 16, 2023 and November 29, 2023.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

During the three months ended October 31, 2023, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions, or written plans for the purchase or sale of the Company’s securities as follows:

•On October 9, 2023, Richard P. Wong, a member of our board of directors, on behalf of a family trust, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act to sell, between January 8, 2024 and April 8, 2024, up to 500,000 shares of our Class A common stock, subject to limit prices.

•On September 22, 2023, Ashim Gupta, our CFO, adopted the following trading plans intended to be treated as one trading plan and to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act:

◦to sell, between January 4, 2024 and June 30, 2024, up to 315,000 shares of our Class A common stock, subject to limit prices.

◦on behalf of a family trust, to sell, between January 4, 2024 and June 30, 2024, up to 96,000 shares of our Class A common stock, subject to limit prices.

Item 6. Exhibits.


Exhibit Number						Description

31.1						Certification of Co-Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2						Certification of Co-Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.3						Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1^						Certification of Co-Chief Executive Officers and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.SCH						XBRL Taxonomy Extension Schema Document
101.CAL						XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF						XBRL Taxonomy Extension Definition Linkbase Document
101.LAB						XBRL Taxonomy Extension Label Linkbase Document
101.PRE						XBRL Taxonomy Extension Presentation Linkbase Document
104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
^						The certification furnished in Exhibit 32.1 hereto is deemed to accompany this Quarterly Report on Form 10-Q and is not deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, irrespective of any general incorporation language contained in such filing.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	UiPath, Inc.

Date: December 4, 2023	By:	/s/ Ashim Gupta
		Ashim Gupta
		Chief Financial Officer (Principal Financial Officer)

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Daniel Dines, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of UiPath, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: December 4, 2023	By:	/s/ Daniel Dines
		Daniel Dines
		Co-Chief Executive Officer, Co-Founder, and Chairman

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert Enslin, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of UiPath, Inc.;

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: December 4, 2023	By:	/s/ Robert Enslin
		Robert Enslin
		Co-Chief Executive Officer

Exhibit 31.3

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ashim Gupta, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of UiPath, Inc.;

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: December 4, 2023	By:	/s/ Ashim Gupta
		Ashim Gupta
		Chief Financial Officer

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of UiPath, Inc. (the “Company”) on Form 10-Q for the quarter ended October 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Daniel Dines, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: December 4, 2023	By:	/s/ Daniel Dines
		Daniel Dines
		Co-Chief Executive Officer, Co-Founder, and Chairman

In connection with the Quarterly Report of UiPath, Inc. (the “Company”) on Form 10-Q for the quarter ended October 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert Enslin, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: December 4, 2023	By:	/s/ Robert Enslin
		Robert Enslin
		Co-Chief Executive Officer

In connection with the Quarterly Report of UiPath, Inc. (the “Company”) on Form 10-Q for the quarter ended October 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ashim Gupta, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: December 4, 2023	By:	/s/ Ashim Gupta
		Ashim Gupta
		Chief Financial Officer

Cover - shares	9 Months Ended
Cover - shares	Oct. 31, 2023	Dec. 01, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2023
Document Transition Report	false
Entity File Number	001-40348
Entity Registrant Name	UiPath, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4333187
Entity Address, Address Line One	One Vanderbilt Avenue, 60th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	844
Local Phone Number	432-0455
Title of 12(b) Security	Class A common stock, par value$0.00001 per share
Trading Symbol	PATH
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Entity Central Index Key	0001734722
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--01-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		483,625,511
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		82,452,748

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Current assets
Cash and cash equivalents	$ 1,003,080	$ 1,402,119
Restricted cash	444	0
Marketable securities	814,097	354,774
Accounts receivable, net of allowance for credit losses of $1,023 and $2,698, respectively	373,091	374,217
Contract assets	84,164	69,260
Deferred contract acquisition costs	63,553	49,887
Prepaid expenses and other current assets	91,224	94,150
Total current assets	2,429,653	2,344,407
Marketable securities, non-current	0	2,942
Contract assets, non-current	6,078	6,523
Deferred contract acquisition costs, non-current	139,932	137,616
Property and equipment, net	22,504	29,045
Operating lease right-of-use assets	53,711	52,052
Intangible assets, net	16,460	23,010
Goodwill	87,293	88,010
Deferred tax assets	5,143	5,895
Other assets, non-current	26,284	45,706
Total assets	2,787,058	2,735,206
Current liabilities
Accounts payable	13,664	8,891
Accrued expenses and other current liabilities	108,014	76,645
Accrued compensation and employee benefits	100,170	142,582
Deferred revenue	405,837	398,334
Total current liabilities	627,685	626,452
Deferred revenue, non-current	132,600	121,697
Operating lease liabilities, non-current	57,687	56,442
Other liabilities, non-current	7,873	10,457
Total liabilities	825,845	815,048
Commitments and contingencies (Note 11)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding	0	0
Treasury stock, at cost, 3,239 shares and none, respectively	(52,649)	0
Additional paid-in capital	3,958,795	3,736,838
Accumulated other comprehensive income	3,158	7,612
Accumulated deficit	(1,948,097)	(1,824,298)
Total stockholders’ equity	1,961,213	1,920,158
Total liabilities and stockholders’ equity	2,787,058	2,735,206
Class A Common Stock
Stockholders' equity
Common stock	5	5
Class B Common Stock
Stockholders' equity
Common stock	$ 1	$ 1

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Accounts receivable, allowance for doubtful accounts	$ 1,023	$ 2,698
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	20,000	20,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock, at cost (in shares)	3,239	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	2,000,000	2,000,000
Common stock, shares issued (in shares)	488,021	474,160
Common stock, shares outstanding (in shares)	484,782	474,160
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	115,741	115,741
Common stock, shares issued (in shares)	82,453	82,453
Common stock, shares outstanding (in shares)	82,453	82,453

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Revenue:
Total revenue	$ 325,921	$ 262,744	$ 902,819	$ 750,032
Cost of revenue:
Total cost of revenue	49,920	42,768	142,574	132,360
Gross profit	276,001	219,976	760,245	617,672
Operating expenses:
Sales and marketing	191,282	156,469	521,413	527,798
Research and development	84,514	67,341	246,462	203,880
General and administrative	56,024	63,157	172,185	189,130
Total operating expenses	331,820	286,967	940,060	920,808
Operating loss	(55,819)	(66,991)	(179,815)	(303,136)
Interest income	14,483	9,561	41,913	15,057
Other income (expense), net	13,725	888	25,491	(2,523)
Loss before income taxes	(27,611)	(56,542)	(112,411)	(290,602)
Provision for income taxes	3,926	1,182	11,388	10,061
Net loss	$ (31,537)	$ (57,724)	$ (123,799)	$ (300,663)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)	$ (0.10)	$ (0.22)	$ (0.55)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)	$ (0.10)	$ (0.22)	$ (0.55)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	567,036	550,164	562,651	546,087
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	567,036	550,164	562,651	546,087
Licenses
Revenue:
Total revenue	$ 148,068	$ 118,175	$ 401,407	$ 338,875
Cost of revenue:
Total cost of revenue	2,781	3,208	8,336	7,915
Subscription services
Revenue:
Total revenue	167,529	130,159	473,880	370,309
Cost of revenue:
Total cost of revenue	28,647	20,578	78,502	63,949
Professional services and other
Revenue:
Total revenue	10,324	14,410	27,532	40,848
Cost of revenue:
Total cost of revenue	$ 18,492	$ 18,982	$ 55,736	$ 60,496

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (31,537)	$ (57,724)	$ (123,799)	$ (300,663)
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale marketable securities, net	277	(324)	259	(625)
Foreign currency translation adjustments	(8,625)	(3,873)	(4,713)	(3,321)
Other comprehensive loss, net	(8,348)	(4,197)	(4,454)	(3,946)
Comprehensive loss	$ (39,885)	$ (61,921)	$ (128,253)	$ (304,609)

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2022				458,773	82,453
Beginning balance at Jan. 31, 2022	$ 1,921,917			$ 4	$ 1		$ 3,406,959	$ 10,899	$ (1,495,946)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,283
Issuance of common stock upon exercise of stock options	2,683						2,683
Vesting of early exercised stock options	1,355						1,355
Issuance of common stock upon settlement of restricted stock units (in shares)				3,499
Tax withholdings on settlement of restricted stock units (in shares)				(1,125)
Tax withholdings on settlement of restricted stock units	(24,827)						(24,827)
Stock-based compensation	102,085						102,085
Other comprehensive income (loss), net	(458)							(458)
Net loss	(122,561)								(122,561)
Ending balance (in shares) at Apr. 30, 2022				462,430	82,453
Ending balance at Apr. 30, 2022	1,880,194			$ 4	$ 1		3,488,255	10,441	(1,618,507)
Beginning balance (in shares) at Jan. 31, 2022				458,773	82,453
Beginning balance at Jan. 31, 2022	1,921,917			$ 4	$ 1		3,406,959	10,899	(1,495,946)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss), net	(3,946)
Net loss	(300,663)	$ (255,266)	$ (45,397)
Ending balance (in shares) at Oct. 31, 2022				469,924	82,453
Ending balance at Oct. 31, 2022	1,859,824			$ 5	$ 1		3,649,474	6,953	(1,796,609)
Beginning balance (in shares) at Apr. 30, 2022				462,430	82,453
Beginning balance at Apr. 30, 2022	1,880,194			$ 4	$ 1		3,488,255	10,441	(1,618,507)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,418
Issuance of common stock upon exercise of stock options	1,878						1,878
Issuance of common stock upon settlement of restricted stock units (in shares)				3,183
Issuance of common stock upon settlement of restricted stock units	1			$ 1
Tax withholdings on settlement of restricted stock units (in shares)				(1,040)
Tax withholdings on settlement of restricted stock units	(18,922)						(18,922)
Charitable donation of Class A common stock (in shares)				300
Charitable donation of Class A common stock	5,499						5,499
Shares issued in connection with business acquisition (in shares)				570
Shares issued in connection with business acquisition	2,965						2,965
Issuance of common stock under employee stock purchase plan (in shares)				578
Issuance of common stock under employee stock purchase plan	9,070						9,070
Repurchase of unvested early exercised stock options (in shares)				(441)
Stock-based compensation	88,533						88,533
Other comprehensive income (loss), net	709							709
Net loss	(120,378)								(120,378)
Ending balance (in shares) at Jul. 31, 2022				466,998	82,453
Ending balance at Jul. 31, 2022	1,849,549			$ 5	$ 1		3,577,278	11,150	(1,738,885)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,087
Issuance of common stock upon exercise of stock options	2,889						2,889
Issuance of common stock upon settlement of restricted stock units (in shares)				2,790
Tax withholdings on settlement of restricted stock units (in shares)				(951)
Tax withholdings on settlement of restricted stock units	(11,998)						(11,998)
Stock-based compensation	81,305						81,305
Other comprehensive income (loss), net	(4,197)							(4,197)
Net loss	(57,724)	$ (49,073)	$ (8,651)						(57,724)
Ending balance (in shares) at Oct. 31, 2022				469,924	82,453
Ending balance at Oct. 31, 2022	1,859,824			$ 5	$ 1		3,649,474	6,953	(1,796,609)
Beginning balance (in shares) at Jan. 31, 2023		474,160	82,453	474,160	82,453
Beginning balance at Jan. 31, 2023	1,920,158			$ 5	$ 1		3,736,838	7,612	(1,824,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				898
Issuance of common stock upon exercise of stock options	1,175						1,175
Issuance of common stock upon settlement of restricted stock units (in shares)				4,246
Tax withholdings on settlement of restricted stock units (in shares)				(1,463)
Tax withholdings on settlement of restricted stock units	(25,697)						(25,697)
Charitable donation of Class A common stock (in shares)				281
Charitable donation of Class A common stock	4,215						4,215
Stock-based compensation	85,125						85,125
Other comprehensive income (loss), net	2,462							2,462
Net loss	(31,901)								(31,901)
Ending balance (in shares) at Apr. 30, 2023				478,122	82,453
Ending balance at Apr. 30, 2023	1,955,537			$ 5	$ 1		3,801,656	10,074	(1,856,199)
Beginning balance (in shares) at Jan. 31, 2023		474,160	82,453	474,160	82,453
Beginning balance at Jan. 31, 2023	$ 1,920,158			$ 5	$ 1		3,736,838	7,612	(1,824,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	3,559
Repurchase of Class A common stock (in shares)				(3,200)
Charitable donation of Class A common stock (in shares)				300
Other comprehensive income (loss), net	$ (4,454)
Net loss	(123,799)	$ (105,657)	$ (18,142)
Ending balance (in shares) at Oct. 31, 2023		488,021	82,453	488,021	82,453	(3,239)
Ending balance at Oct. 31, 2023	1,961,213			$ 5	$ 1	$ (52,649)	3,958,795	3,158	(1,948,097)
Beginning balance (in shares) at Apr. 30, 2023				478,122	82,453
Beginning balance at Apr. 30, 2023	1,955,537			$ 5	$ 1		3,801,656	10,074	(1,856,199)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,824
Issuance of common stock upon exercise of stock options	2,717						2,717
Issuance of common stock upon settlement of restricted stock units (in shares)				5,026
Tax withholdings on settlement of restricted stock units (in shares)				(1,676)
Tax withholdings on settlement of restricted stock units	(27,420)						(27,420)
Issuance of common stock under employee stock purchase plan (in shares)				832
Issuance of common stock under employee stock purchase plan	9,313						9,313
Stock-based compensation	102,148						102,148
Other comprehensive income (loss), net	1,432							1,432
Net loss	(60,361)								(60,361)
Ending balance (in shares) at Jul. 31, 2023				484,128	82,453	0
Ending balance at Jul. 31, 2023	1,983,366			$ 5	$ 1	$ 0	3,888,414	11,506	(1,916,560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				837
Issuance of common stock upon exercise of stock options	1,516						1,516
Vesting of early exercised stock options	1						1
Issuance of common stock upon settlement of restricted stock units (in shares)				4,639
Tax withholdings on settlement of restricted stock units (in shares)				(1,583)
Tax withholdings on settlement of restricted stock units	(27,047)						(27,047)
Repurchase of Class A common stock (in shares)				(3,200)		(3,239)
Repurchase of Class A common stock	(52,649)					$ (52,649)
Stock-based compensation	95,911						95,911
Other comprehensive income (loss), net	(8,348)							(8,348)
Net loss	(31,537)	$ (26,951)	$ (4,586)						(31,537)
Ending balance (in shares) at Oct. 31, 2023		488,021	82,453	488,021	82,453	(3,239)
Ending balance at Oct. 31, 2023	$ 1,961,213			$ 5	$ 1	$ (52,649)	$ 3,958,795	$ 3,158	$ (1,948,097)

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Cash flows from operating activities
Net loss	$ (123,799)	$ (300,663)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	16,555	12,993
Amortization of deferred contract acquisition costs	52,828	37,967
Net amortization on marketable securities	(19,556)	501
Stock-based compensation expense	283,025	270,797
Charitable donation of Class A common stock	4,215	5,499
Amortization of operating lease right-of-use assets	9,663	8,555
Provision for deferred income taxes	(1,040)	1,171
Abandonment and impairment charges	0	2,881
Other non-cash credits, net	(4,864)	(1,714)
Changes in operating assets and liabilities:
Accounts receivable	(1,507)	(33,449)
Contract assets	(14,875)	(27,735)
Deferred contract acquisition costs	(71,727)	(69,657)
Prepaid expenses and other assets	17,247	(27,361)
Accounts payable	5,767	2,414
Accrued expenses and other liabilities	22,309	(13,785)
Accrued compensation and employee benefits	(40,590)	(26,096)
Operating lease liabilities, net	(10,296)	(488)
Deferred revenue	30,125	54,232
Net cash provided by (used in) operating activities	153,480	(103,938)
Cash flows from investing activities
Purchases of marketable securities	(1,006,606)	(204,311)
Maturities of marketable securities	576,480	93,298
Purchases of property and equipment	(3,558)	(21,614)
Payments related to business acquisition, net of cash acquired	0	(29,542)
Other investing, net	2,754	(507)
Net cash used in investing activities	(430,930)	(162,676)
Cash flows from financing activities
Repurchases of Class A common stock	(52,649)	0
Proceeds from exercise of stock options	5,421	7,605
Payments of tax withholdings on net settlement of equity awards	(75,495)	(53,300)
Net payments of tax withholdings on sell-to-cover equity award transactions	(645)	(10,132)
Proceeds from employee stock purchase plan contributions	14,253	13,525
Payment of deferred consideration related to business acquisition	(5,863)	0
Repurchase of unvested early exercised stock options	0	(1,493)
Net cash used in financing activities	(114,978)	(43,795)
Effect of exchange rate changes	(6,167)	(7,162)
Net decrease in cash, cash equivalents, and restricted cash	(398,595)	(317,571)
Cash, cash equivalents, and restricted cash - beginning of period	1,402,119	1,768,723
Cash, cash equivalents, and restricted cash - end of period	1,003,524	1,451,152
Supplemental disclosure of cash flow information
Cash paid for interest	515	720
Cash paid for income taxes	9,136	19,060
Supplemental disclosure of non-cash investing and financing activities
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options	1	1,355
Value of shares issued in payment of business acquisitions	0	2,965
Payable for marketable securities purchase	9,747	2,894
Loan notes issued in connection with business acquisitions	0	11,433
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid	$ 6,833	$ 2,517

Organization and Description of Business	9 Months Ended
Organization and Description of Business	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. Our AI-powered UiPath Business Automation Platform offers a robust set of capabilities that allows our customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale.

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Oct. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Our significant accounting policies are discussed in greater scope and detail in Note 2, Summary of Significant Accounting Policies, in the notes to consolidated financial statements included in the 2023 Form 10-K. There have been no significant changes to such policies during the nine months ended October 31, 2023. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2023, which are included in the 2023 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the nine months ended October 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2024 or for any other future interim or annual period. Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2024, for example, refer to the fiscal year ending January 31, 2024. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition including changes in variable consideration, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions. Foreign Currency The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations. For the three months ended October 31, 2023 and 2022, we recognized transaction gains (losses) of $4.3 million and $(0.4) million, respectively. For the nine months ended October 31, 2023 and 2022, we recognized transaction gains (losses) of $2.9 million and $(2.6) million, respectively. Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of October 31, 2023 and January 31, 2023, 93% and 98%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan. The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints. With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three and nine months ended October 31, 2023 and 2022, no single customer accounted for 10% or more of our total revenue. As of October 31, 2023, one customer accounted for 12% of our accounts receivable. As of January 31, 2023, no single customer accounted for 10% or more of our accounts receivable. Stock-Based Compensation We recognize stock-based compensation expense in accordance with the provisions of Accounting Standards Codification ("ASC") 718, Compensation—Stock Compensation. ASC 718 requires the measurement and recognition of compensation expense for all stock-based awards made to employees, directors, and non-employees based on the grant date fair value of the awards. The fair value of each stock option is determined using the Black-Scholes pricing model. The fair value of each restricted stock unit ("RSU") and restricted stock award ("RSA") is determined based on the fair value of our Class A common stock on the grant date. The fair value of each performance stock unit ("PSU") that is dependent on the satisfaction of a performance condition is also determined based on the fair value of our Class A common stock on the grant date.The fair value of shares under our employee stock purchase plan ("ESPP") is determined using the Black-Scholes pricing model. Stock-based compensation expense is included in cost of revenue and operating expenses within our consolidated statements of operations based on the expense classification of the individual earning the award. The fair value of awards with only service-based vesting conditions is recognized as expense over the requisite service period on a straight-line basis. For PSUs dependent on the satisfaction of a performance condition, compensation expense is recognized only when management believes it is probable that the performance condition will be achieved. Although total compensation expense recognized for these awards will ultimately equal the grant date fair value per share multiplied by the number of shares earned by the holder, changes in management's expectations can cause fluctuations in timing of expense over the life of these awards. The fair value of ESPP shares is recognized over the relevant offering period on a straight-line basis. With all award types, we account for forfeitures as they occur. Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

Revenue Recognition

9 Months Ended

Oct. 31, 2023

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Disaggregation of Revenue

The following tables summarize revenue by geographical region (dollars in thousands):


	Three Months Ended October 31,
	2023				2022
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	174,226	53	%	$	147,312	56	%
Europe, Middle East, and Africa	93,782		29	%	65,880		25	%
Asia-Pacific (2)	57,913		18	%	49,552		19	%
Total revenue	$	325,921	100	%	$	262,744	100	%

(1)Revenue from the U.S. represented 48% and 52% of our total revenues for the three months ended October 31, 2023 and 2022, respectively.

(2)Revenue from Japan represented 7% and 7% of our total revenues for the three months ended October 31, 2023 and 2022, respectively.


	Nine Months Ended October 31,
	2023				2022
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	437,396	48	%	$	382,440	51	%
Europe, Middle East, and Africa	271,722		30	%	205,004		27	%
Asia-Pacific (2)	193,701		22	%	162,588		22	%
Total revenue	$	902,819	100	%	$	750,032	100	%

(1)Revenue from the U.S. represented 44% and 47% of our total revenues for the nine months ended October 31, 2023 and 2022, respectively.

(2)Revenue from Japan represented 10% and 10% of our total revenues for the nine months ended October 31, 2023 and 2022, respectively.

Deferred Revenue

Remaining Performance Obligations

Deferred Contract Acquisition Costs

Marketable Securities

9 Months Ended

Oct. 31, 2023

Investments, Debt and Equity Securities [Abstract]

Marketable Securities

The following is a summary of our marketable securities (in thousands):


	As of October 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	23,853	$	—	$	—	$	23,853
Treasury bills and U.S. government securities	602,927		—		(150)		602,777
Corporate bonds	5,625		—		(14)		5,611
Municipal bonds	1,000		—		(2)		998
Agency bonds	181,054		—		(196)		180,858
Total marketable securities	$	814,459	$	—	$	(362)	$	814,097


	As of January 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	62,470	$	—	$	—	$	62,470
Treasury bills and U.S. government securities (1)	234,848		—		(308)		234,540
Corporate bonds	46,684		—		(198)		46,486
Municipal bonds	6,374		—		(66)		6,308
Agency bonds	7,959		—		(47)		7,912
Total marketable securities	$	358,335	$	—	$	(619)	$	357,716
(1) Treasury bills with both amortized cost and estimated fair value of $10.0 million are included in cash and cash equivalents due to their original maturity of three months or less.

As of October 31, 2023 and January 31, 2023, none and $2.9 million, respectively, of our marketable securities had remaining contractual maturities of one year or more.

Fair Value Measurement

9 Months Ended

Oct. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurement

The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of October 31, 2023 and January 31, 2023 (in thousands):


	As of October 31, 2023
	Level 1		Level 2		Total

Money market	$	468,683	$	—	$	468,683



Total cash equivalents	468,683		—		468,683
Commercial paper	—		23,853		23,853
Treasury bills and U.S. government securities	602,777		—		602,777
Corporate bonds	—		5,611		5,611
Municipal bonds	—		998		998
Agency bonds	180,858		—		180,858
Total marketable securities	783,635		30,462		814,097
Total	$	1,252,318	$	30,462	$	1,282,780


	As of January 31, 2023
	Level 1		Level 2		Total

Money market	$	319,801	$	—	$	319,801
Treasury bills	9,968		—		9,968
Total cash equivalents	329,769		—		329,769
Commercial paper	—		62,470		62,470
Treasury bills and U.S. government securities	234,540		—		234,540
Corporate bonds	—		46,486		46,486
Municipal bonds	—		6,308		6,308
Agency bonds	7,912		—		7,912
Total marketable securities	242,452		115,264		357,716
Total	$	572,221	$	115,264	$	687,485

Business Acquisition

9 Months Ended

Oct. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Business Acquisition

Re:infer

The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following (in thousands):


Cash paid at closing	$	30,117
Fair value of Class A common stock issued at closing (0.2 million shares)	2,965
Loan note paid on July 29, 2023 (first anniversary of closing)	5,863
Loan note to be paid on second anniversary of closing (included in accrued expenses and other current liabilities as of October 31, 2023)	5,570
Working capital adjustment	66
Total	$	44,581

The following table summarizes the fair values of the assets acquired and liabilities assumed as of the acquisition date (in thousands):


	July 29, 2022
Net tangible assets	$	300
Intangible assets	13,100
Goodwill	34,351
Total assets acquired	47,751
Deferred tax liabilities assumed	(3,170)
Total	$	44,581

The following table sets forth the identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition:


	Fair Value (in thousands)		Estimated Useful Life (in years)
Developed technology	$	10,000	5.0
Customer relationships	3,100		3.0
Total	$	13,100

The acquisition of Re:infer generated goodwill of $34.4 million representing expected synergies and acquired skilled workforce. None of this goodwill is deductible for tax purposes.

Intangible Assets and Goodwill

9 Months Ended

Oct. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill

Intangible Assets, Net

Acquired intangible assets, net consisted of the following as of October 31, 2023 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (in years)
Developed technology	$	28,241	$	(15,206)	$	13,035	3.0
Customer relationships	8,135		(5,577)		2,558		1.4
Trade names and trademarks	271		(257)		14		0.4
Other intangibles	1,231		(378)		853		7.2
Total	$	37,878	$	(21,418)	$	16,460

Acquired intangible assets, net consisted of the following as of January 31, 2023 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (in years)
Developed technology	$	28,517	$	(11,095)	$	17,422	3.5
Customer relationships	8,174		(3,601)		4,573		2.0
Trade names and trademarks	272		(233)		39		1.2
Other intangibles	1,231		(255)		976		7.7
Total	$	38,194	$	(15,184)	$	23,010

Expected future amortization expense related to intangible assets was as follows as of October 31, 2023 (in thousands):


	Amount
Remainder of year ending January 31, 2024	$	2,123
Year ending January 31,
2025	6,538
2026	4,004
2027	2,369
2028	1,123
Thereafter	303
Total	$	16,460

Goodwill

Changes in the carrying amount of goodwill during the nine months ended October 31, 2023 were as follows (in thousands):


	Carrying Amount
Balance as of January 31, 2023	$	88,010

Effect of foreign currency translation	(717)
Balance as of October 31, 2023	$	87,293

Operating Leases

9 Months Ended

Oct. 31, 2023

Leases [Abstract]

Operating Leases

Lease costs are presented below (in thousands):


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Operating lease cost	$	3,364	$	3,060	$	9,663	$	8,555
Short-term lease cost	1,225		1,509		3,845		4,552
Variable lease cost	493		362		1,639		885
Sublease income (1)	(426)		(532)		(1,491)		(1,597)
Total	$	4,656	$	4,399	$	13,656	$	12,395

(1) Included in other income (expense), net in the condensed consolidated statements of operations.

The following table represents the weighted-average remaining lease term and discount rate as of the periods presented:


	As of
	October 31, 2023		January 31, 2023
Weighted-average remaining lease term (years)	11.2		12.1
Weighted-average discount rate	7.0	%	7.0	%

Future undiscounted lease payments for our operating lease liabilities as of October 31, 2023 were as follows (in thousands):


	Amount
Remainder of year ending January 31, 2024	$	1,849
Year ending January 31,
2025	12,284
2026	10,173
2027	9,432
2028	8,748
Thereafter	49,931
Total operating lease payments	92,417
Less: imputed interest	(27,825)
Total operating lease liabilities	$	64,592

As of October 31, 2023, we had non-cancellable commitments in the amount of $0.5 million related to operating leases of real estate facilities that have not yet commenced.

Supplemental cash flow information related to leases for the three and nine months ended October 31, 2023 and 2022 was as follows (in thousands):


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Cash paid for amounts included in the measurement of operating lease liabilities	$	3,486	$	1,721	$	9,646	$	5,278
Operating lease ROU assets obtained in exchange for new operating lease liabilities	4,139		5,769		8,820		8,659

Condensed Consolidated Balance Sheet Components

9 Months Ended

Oct. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Consolidated Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of
	October 31, 2023		January 31, 2023
Prepaid expenses and service credits	$	65,755	$	67,794
Other current assets	25,469		26,356
Prepaid expenses and other current assets	$	91,224	$	94,150

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of
	October 31, 2023		January 31, 2023
Computers and equipment	$	28,164	$	28,450
Leasehold improvements	21,860		19,622
Furniture and fixtures	6,751		6,485
Construction in progress	533		2,419
Property and equipment, gross	57,308		56,976
Less: accumulated depreciation	(34,804)		(27,931)
Property and equipment, net	$	22,504	$	29,045

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	As of
	October 31, 2023		January 31, 2023
Accrued expenses	$	25,079	$	19,411
Withholding tax from employee equity transactions	6,950		3,772
Employee stock purchase plan withholdings	8,217		3,365
Payroll taxes and other benefits payable	6,722		7,644
Income tax payable	12,774		8,750
Value-added taxes payable	4,342		6,381
Operating lease liabilities, current	6,905		6,997
Deferred consideration for business acquisition, current	5,570		5,863
Payable for marketable securities purchase (1)	9,747		3,588
Other	21,708		10,874
Accrued expenses and other current liabilities	$	108,014	$	76,645
(1) Prior period amount has been broken out to conform with current period presentation

Credit Facility	9 Months Ended
Credit Facility	Oct. 31, 2023
Debt Disclosure [Abstract]
Credit Facility	Credit Facility On October 30, 2020 we entered into a $200.0 million senior secured revolving credit facility with a maturity date of October 30, 2023 (as subsequently amended, the “Credit Facility”) with HSBC Ventures USA Inc., Silicon Valley Bank, a division of First Citizens Bank & Trust Company (successor by purchase to the FDIC as receiver for Silicon Valley Bridge Bank, N.A. (as successor to Silicon Valley Bank)), Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD (together, the "Lenders"). The Credit Facility contained certain customary covenants, including, but not limited to, those relating to additional indebtedness, liens, asset divestitures, and affiliate transactions. We did not borrow under the Credit Facility at any time. In September 2023, we and the Lenders terminated the Credit Facility prior to its original maturity date

Commitments and Contingencies

9 Months Ended

Oct. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Letters of Credit

Indemnification

Restructuring


	Employee Termination Benefits
Accrued restructuring costs as of January 31, 2023	$	3,889
Restructuring costs incurred during the nine months ended October 31, 2023	2,631
Amount paid during the nine months ended October 31, 2023	(6,072)
Accrued restructuring costs as of October 31, 2023	$	448

Defined Contribution Plans

Litigation

We have not recorded any accrual related to the aforementioned litigation matters as of October 31, 2023.

Warranty

Non-Cancelable Purchase Obligations

As of October 31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands):


	Amount
Remainder of year ending January 31, 2024	$	11,164
Year ending January 31,
2025	91,225
2026	64,667
2027	21,679
2028	8,245
Thereafter	—
Total	$	196,980

Stockholders' Equity

9 Months Ended

Oct. 31, 2023

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

Stock Repurchase Program

During the three and nine months ended October 31, 2023, we repurchased 3.2 million shares of our Class A common stock at an average price of $16.26 per share (inclusive of brokerage commission).

Subsequent to October 31, 2023, between November 1, 2023 and November 28, 2023, we repurchased an additional 1.7 million shares of our Class A common stock at an average price of $17.38 per share.

Charitable Donations of Class A Common Stock

Accumulated Other Comprehensive Income (Loss)

For the nine months ended October 31, 2023 and 2022, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands):


	Foreign Currency Translation Adjustments		Unrealized Gain (Loss) on Marketable Securities		Accumulated Other Comprehensive Income (Loss)
Balance as of January 31, 2023	$	8,231	$	(619)	$	7,612
Other comprehensive (loss) income, net of tax	(4,713)		259		(4,454)
Balance as of October 31, 2023	$	3,518	$	(360)	$	3,158


	Foreign Currency Translation Adjustments		Unrealized Gain (Loss) on Marketable Securities		Accumulated Other Comprehensive Income (Loss)
Balance as of January 31, 2022	$	11,234	$	(335)	$	10,899
Other comprehensive loss, net of tax	(3,321)		(625)		(3,946)
Balance as of October 31, 2022	$	7,913	$	(960)	$	6,953

Equity Incentive Plans and Stock-Based Compensation

9 Months Ended

Oct. 31, 2023

Share-Based Payment Arrangement [Abstract]

Equity Incentive Plans and Stock-Based Compensation

2021 Stock Plan

2021 Employee Stock Purchase Plan

Stock Options

Stock option activity during the nine months ended October 31, 2023 was as follows:


	Stock Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2023	13,898	$	3.32	7.7	$	169,324
Granted	2,763	$	0.10
Exercised	(3,559)	$	1.52
Forfeited	(361)	$	0.51
Outstanding as of October 31, 2023	12,741	$	3.20	7.6	$	158,811

Vested and exercisable as of October 31, 2023	6,252	$	3.68	6.4	$	74,680

Restricted Stock Units

RSU activity during the nine months ended October 31, 2023 was as follows:


	RSUs (in thousands)	Weighted-Average Grant Date Fair Value Per Share
Unvested as of January 31, 2023	36,785	$	22.48
Granted	17,615	$	16.54
Vested	(13,773)	$	20.47
Forfeited	(6,569)	$	23.46
Unvested as of October 31, 2023	34,058	$	20.03

The vesting date fair value of RSUs that vested during the nine months ended October 31, 2023 was $236.2 million.

Restricted Stock Awards

Performance Stock Units

Employee Stock Purchase Plan Awards

Stock-Based Compensation Associated with Business Acquisition

Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands):


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Cost of subscription services revenue	$	3,791	$	2,844	$	10,778	$	8,901
Cost of professional services and other revenue	2,764		2,557		8,546		8,959
Sales and marketing	37,760		30,763		109,890		117,410
Research and development	30,604		23,435		88,448		73,559
General and administrative	20,961		21,492		65,363		61,968
Total	$	95,880	$	81,091	$	283,025	$	270,797

Income Taxes	9 Months Ended
Income Taxes	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences. We had a provision for income taxes of $3.9 million, reflecting an effective tax rate of (14.2%), and $1.2 million, reflecting an effective tax rate of (2.1%), for the three months ended October 31, 2023 and 2022, respectively. For the three months ended October 31, 2023 and 2022, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets ("DTAs") for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries. We had a provision for income taxes of $11.4 million, reflecting an effective tax rate of (10.1%), and $10.1 million, reflecting an effective tax rate of (3.5%), for the nine months ended October 31, 2023 and 2022, respectively. For the nine months ended October 31, 2023 and 2022, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing DTAs for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries. The realization of tax benefits of net DTAs is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the nine months ended October 31, 2023, we believe it is more likely than not that the tax benefits of DTAs associated with the U.S., Romania, and the U.K. may not be realized. Accordingly, we recorded a full valuation allowance against U.S., Romania, and U.K. DTAs. We intend to maintain each of these full valuation allowances until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance. As of October 31, 2023, there is no valuation allowance recorded against DTAs associated with Japan as we believe it is more likely than not that we will realize such assets during the prescribed statutory period. As of October 31, 2023, we had gross unrecognized tax benefits totaling $2.3 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $1.5 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. The tax positions of UiPath, Inc. and its subsidiaries are subject to income tax audits in multiple tax jurisdictions globally, with currently open audits in Romania and India, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. At this time, we do not expect any significant changes in the next fiscal quarter based on the current positions undertaken by us. During the three months ended October 31, 2023, Romania adopted a minimum alternative corporate income tax that is applicable to all companies, including those reporting a net loss, for tax years commencing after January 1, 2024. Given our presence in Romania, we expect this change to increase our effective tax rate and immaterially increase our provision for income taxes for fiscal year 2025.

Net Loss Per Share Attributable to Common Stockholders

9 Months Ended

Oct. 31, 2023

Earnings Per Share [Abstract]

Net Loss Per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts):


	Three Months Ended October 31,
	2023				2022
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(26,951)	$	(4,586)	$	(49,073)	$	(8,651)



Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	484,583		82,453		467,711		82,453
Net loss per share attributable to common stockholders, basic and diluted	$	(0.06)	$	(0.06)	$	(0.10)	$	(0.10)


	Nine Months Ended October 31,
	2023				2022
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(105,657)	$	(18,142)	$	(255,266)	$	(45,397)



Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	480,198		82,453		463,634		82,453
Net loss per share attributable to common stockholders, basic and diluted	$	(0.22)	$	(0.22)	$	(0.55)	$	(0.55)

Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands):


	Three Months Ended October 31,
	2023		2022
	Class A	Class B	Class A	Class B

Unvested RSUs	36,911	—	31,022	—
Outstanding stock options	13,207	—	13,812	—
Shares subject to repurchase from RSAs and early exercised stock options	52	—	104	—
Shares issuable under ESPP	714	—	936	—
Returnable shares issued in connection with business acquisition	274	—	427	—
Total	51,158	—	46,301	—


	Nine Months Ended October 31,
	2023		2022
	Class A	Class B	Class A	Class B
Unvested RSUs	38,137	—	29,307	—
Outstanding stock options	13,764	—	13,913	—
Shares subject to repurchase from RSAs and early exercised stock options	56	—	355	—
Shares issuable under ESPP	762	—	851	—
Returnable shares issued in connection with business acquisition	374	—	149	—
Total	53,093	—	44,575	—

Related Party Transactions	9 Months Ended
Related Party Transactions	Oct. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Beginning in the third quarter of fiscal year 2022, we have at times made use of an aircraft which is owned by Daniel Dines, our Co-Chief Executive Officer, through a special purpose limited liability company and which is operated by a third-party aircraft management company. Mr. Dines, through the special purpose limited liability company, obtained financing for the aircraft and bears all associated operating, personnel, and maintenance costs. We did not incur any expense related to use of the aircraft for the three and nine months ended October 31, 2023. For the three and nine months ended October 31, 2022, we incurred no expense and $1.9 million of expense, respectively in connection with our business use of the aircraft.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2023	Oct. 31, 2022
Pay vs Performance Disclosure
Net loss	$ (31,537)	$ (60,361)	$ (31,901)	$ (57,724)	$ (120,378)	$ (122,561)	$ (123,799)	$ (300,663)

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Oct. 31, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Richard P.Wong [Member]
Trading Arrangements, by Individual
Name	Richard P. Wong
Title	member of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	October 9, 2023
Arrangement Duration	91 days
Aggregate Available	500,000
Ashim Gupta [Member]
Trading Arrangements, by Individual
Name	Ashim Gupta
Title	CFO
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 22, 2023
Arrangement Duration	178 days
Aggregate Available	315,000
Ashim Gupta Family Trust [Member]
Trading Arrangements, by Individual
Arrangement Duration	178 days
Aggregate Available	96,000

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Oct. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2023, which are included in the 2023 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the nine months ended October 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2024 or for any other future interim or annual period.
Fiscal Year	Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2024, for example, refer to the fiscal year ending January 31, 2024.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition including changes in variable consideration, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.
Foreign Currency	Foreign Currency The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations.
Concentration of Risks	Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of October 31, 2023 and January 31, 2023, 93% and 98%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan. The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints. With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date.
Stock-Based Compensation	Stock-Based Compensation We recognize stock-based compensation expense in accordance with the provisions of Accounting Standards Codification ("ASC") 718, Compensation—Stock Compensation. ASC 718 requires the measurement and recognition of compensation expense for all stock-based awards made to employees, directors, and non-employees based on the grant date fair value of the awards. The fair value of each stock option is determined using the Black-Scholes pricing model. The fair value of each restricted stock unit ("RSU") and restricted stock award ("RSA") is determined based on the fair value of our Class A common stock on the grant date. The fair value of each performance stock unit ("PSU") that is dependent on the satisfaction of a performance condition is also determined based on the fair value of our Class A common stock on the grant date.The fair value of shares under our employee stock purchase plan ("ESPP") is determined using the Black-Scholes pricing model. Stock-based compensation expense is included in cost of revenue and operating expenses within our consolidated statements of operations based on the expense classification of the individual earning the award. The fair value of awards with only service-based vesting conditions is recognized as expense over the requisite service period on a straight-line basis. For PSUs dependent on the satisfaction of a performance condition, compensation expense is recognized only when management believes it is probable that the performance condition will be achieved. Although total compensation expense recognized for these awards will ultimately equal the grant date fair value per share multiplied by the number of shares earned by the holder, changes in management's expectations can cause fluctuations in timing of expense over the life of these awards. The fair value of ESPP shares is recognized over the relevant offering period on a straight-line basis. With all award types, we account for forfeitures as they occur.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

Revenue Recognition (Tables)

9 Months Ended

Oct. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue by Geographical Region

The following tables summarize revenue by geographical region (dollars in thousands):


	Three Months Ended October 31,
	2023				2022
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	174,226	53	%	$	147,312	56	%
Europe, Middle East, and Africa	93,782		29	%	65,880		25	%
Asia-Pacific (2)	57,913		18	%	49,552		19	%
Total revenue	$	325,921	100	%	$	262,744	100	%

(1)Revenue from the U.S. represented 48% and 52% of our total revenues for the three months ended October 31, 2023 and 2022, respectively.

(2)Revenue from Japan represented 7% and 7% of our total revenues for the three months ended October 31, 2023 and 2022, respectively.


	Nine Months Ended October 31,
	2023				2022
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	437,396	48	%	$	382,440	51	%
Europe, Middle East, and Africa	271,722		30	%	205,004		27	%
Asia-Pacific (2)	193,701		22	%	162,588		22	%
Total revenue	$	902,819	100	%	$	750,032	100	%

(1)Revenue from the U.S. represented 44% and 47% of our total revenues for the nine months ended October 31, 2023 and 2022, respectively.

(2)Revenue from Japan represented 10% and 10% of our total revenues for the nine months ended October 31, 2023 and 2022, respectively.

Marketable Securities (Tables)

9 Months Ended

Oct. 31, 2023

Investments, Debt and Equity Securities [Abstract]

Schedule of Marketable Securities

The following is a summary of our marketable securities (in thousands):


	As of October 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	23,853	$	—	$	—	$	23,853
Treasury bills and U.S. government securities	602,927		—		(150)		602,777
Corporate bonds	5,625		—		(14)		5,611
Municipal bonds	1,000		—		(2)		998
Agency bonds	181,054		—		(196)		180,858
Total marketable securities	$	814,459	$	—	$	(362)	$	814,097


	As of January 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	62,470	$	—	$	—	$	62,470
Treasury bills and U.S. government securities (1)	234,848		—		(308)		234,540
Corporate bonds	46,684		—		(198)		46,486
Municipal bonds	6,374		—		(66)		6,308
Agency bonds	7,959		—		(47)		7,912
Total marketable securities	$	358,335	$	—	$	(619)	$	357,716
(1) Treasury bills with both amortized cost and estimated fair value of $10.0 million are included in cash and cash equivalents due to their original maturity of three months or less.

Fair Value Measurement (Tables)

9 Months Ended

Oct. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on Recurring Basis

The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of October 31, 2023 and January 31, 2023 (in thousands):


	As of October 31, 2023
	Level 1		Level 2		Total

Money market	$	468,683	$	—	$	468,683



Total cash equivalents	468,683		—		468,683
Commercial paper	—		23,853		23,853
Treasury bills and U.S. government securities	602,777		—		602,777
Corporate bonds	—		5,611		5,611
Municipal bonds	—		998		998
Agency bonds	180,858		—		180,858
Total marketable securities	783,635		30,462		814,097
Total	$	1,252,318	$	30,462	$	1,282,780


	As of January 31, 2023
	Level 1		Level 2		Total

Money market	$	319,801	$	—	$	319,801
Treasury bills	9,968		—		9,968
Total cash equivalents	329,769		—		329,769
Commercial paper	—		62,470		62,470
Treasury bills and U.S. government securities	234,540		—		234,540
Corporate bonds	—		46,486		46,486
Municipal bonds	—		6,308		6,308
Agency bonds	7,912		—		7,912
Total marketable securities	242,452		115,264		357,716
Total	$	572,221	$	115,264	$	687,485

Business Acquisition (Tables)

9 Months Ended

Oct. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Schedule of Total Purchase Consideration

The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following (in thousands):


Cash paid at closing	$	30,117
Fair value of Class A common stock issued at closing (0.2 million shares)	2,965
Loan note paid on July 29, 2023 (first anniversary of closing)	5,863
Loan note to be paid on second anniversary of closing (included in accrued expenses and other current liabilities as of October 31, 2023)	5,570
Working capital adjustment	66
Total	$	44,581

Schedule of Fair Values of Assets Acquired and Liabilities Assumed

The following table summarizes the fair values of the assets acquired and liabilities assumed as of the acquisition date (in thousands):


	July 29, 2022
Net tangible assets	$	300
Intangible assets	13,100
Goodwill	34,351
Total assets acquired	47,751
Deferred tax liabilities assumed	(3,170)
Total	$	44,581

Schedule of Identifiable Intangible Assets Acquired and their Estimated Useful Lives

The following table sets forth the identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition:


	Fair Value (in thousands)		Estimated Useful Life (in years)
Developed technology	$	10,000	5.0
Customer relationships	3,100		3.0
Total	$	13,100

Intangible Assets and Goodwill (Tables)

9 Months Ended

Oct. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets, Net

Acquired intangible assets, net consisted of the following as of October 31, 2023 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (in years)
Developed technology	$	28,241	$	(15,206)	$	13,035	3.0
Customer relationships	8,135		(5,577)		2,558		1.4
Trade names and trademarks	271		(257)		14		0.4
Other intangibles	1,231		(378)		853		7.2
Total	$	37,878	$	(21,418)	$	16,460

Acquired intangible assets, net consisted of the following as of January 31, 2023 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (in years)
Developed technology	$	28,517	$	(11,095)	$	17,422	3.5
Customer relationships	8,174		(3,601)		4,573		2.0
Trade names and trademarks	272		(233)		39		1.2
Other intangibles	1,231		(255)		976		7.7
Total	$	38,194	$	(15,184)	$	23,010

Schedule of Expected Future Amortization Expenses Related to Intangible Assets

Expected future amortization expense related to intangible assets was as follows as of October 31, 2023 (in thousands):


	Amount
Remainder of year ending January 31, 2024	$	2,123
Year ending January 31,
2025	6,538
2026	4,004
2027	2,369
2028	1,123
Thereafter	303
Total	$	16,460

Schedule of Changes in Carrying Amounts of Goodwill

Changes in the carrying amount of goodwill during the nine months ended October 31, 2023 were as follows (in thousands):


	Carrying Amount
Balance as of January 31, 2023	$	88,010

Effect of foreign currency translation	(717)
Balance as of October 31, 2023	$	87,293

Operating Leases (Tables)

9 Months Ended

Oct. 31, 2023

Leases [Abstract]

Schedule of Lease Costs and Supplemental Cash Flow Information

Lease costs are presented below (in thousands):


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Operating lease cost	$	3,364	$	3,060	$	9,663	$	8,555
Short-term lease cost	1,225		1,509		3,845		4,552
Variable lease cost	493		362		1,639		885
Sublease income (1)	(426)		(532)		(1,491)		(1,597)
Total	$	4,656	$	4,399	$	13,656	$	12,395

(1) Included in other income (expense), net in the condensed consolidated statements of operations.

Supplemental cash flow information related to leases for the three and nine months ended October 31, 2023 and 2022 was as follows (in thousands):


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Cash paid for amounts included in the measurement of operating lease liabilities	$	3,486	$	1,721	$	9,646	$	5,278
Operating lease ROU assets obtained in exchange for new operating lease liabilities	4,139		5,769		8,820		8,659

Schedule of Weighted-average Lease Term and Discount Rate

The following table represents the weighted-average remaining lease term and discount rate as of the periods presented:


	As of
	October 31, 2023		January 31, 2023
Weighted-average remaining lease term (years)	11.2		12.1
Weighted-average discount rate	7.0	%	7.0	%

Schedule of Future Undiscounted Lease Payments for Operating Lease Liabilities

Future undiscounted lease payments for our operating lease liabilities as of October 31, 2023 were as follows (in thousands):


	Amount
Remainder of year ending January 31, 2024	$	1,849
Year ending January 31,
2025	12,284
2026	10,173
2027	9,432
2028	8,748
Thereafter	49,931
Total operating lease payments	92,417
Less: imputed interest	(27,825)
Total operating lease liabilities	$	64,592

Condensed Consolidated Balance Sheet Components (Tables)

9 Months Ended

Oct. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of
	October 31, 2023		January 31, 2023
Prepaid expenses and service credits	$	65,755	$	67,794
Other current assets	25,469		26,356
Prepaid expenses and other current assets	$	91,224	$	94,150

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of
	October 31, 2023		January 31, 2023
Computers and equipment	$	28,164	$	28,450
Leasehold improvements	21,860		19,622
Furniture and fixtures	6,751		6,485
Construction in progress	533		2,419
Property and equipment, gross	57,308		56,976
Less: accumulated depreciation	(34,804)		(27,931)
Property and equipment, net	$	22,504	$	29,045

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	As of
	October 31, 2023		January 31, 2023
Accrued expenses	$	25,079	$	19,411
Withholding tax from employee equity transactions	6,950		3,772
Employee stock purchase plan withholdings	8,217		3,365
Payroll taxes and other benefits payable	6,722		7,644
Income tax payable	12,774		8,750
Value-added taxes payable	4,342		6,381
Operating lease liabilities, current	6,905		6,997
Deferred consideration for business acquisition, current	5,570		5,863
Payable for marketable securities purchase (1)	9,747		3,588
Other	21,708		10,874
Accrued expenses and other current liabilities	$	108,014	$	76,645
(1) Prior period amount has been broken out to conform with current period presentation

Commitments and Contingencies (Tables)

9 Months Ended

Oct. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Accrued Restructuring Costs


	Employee Termination Benefits
Accrued restructuring costs as of January 31, 2023	$	3,889
Restructuring costs incurred during the nine months ended October 31, 2023	2,631
Amount paid during the nine months ended October 31, 2023	(6,072)
Accrued restructuring costs as of October 31, 2023	$	448

Schedule of Non-Cancelable Purchase Obligations

As of October 31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands):


	Amount
Remainder of year ending January 31, 2024	$	11,164
Year ending January 31,
2025	91,225
2026	64,667
2027	21,679
2028	8,245
Thereafter	—
Total	$	196,980

Stockholders' Equity (Tables)

9 Months Ended

Oct. 31, 2023

Equity [Abstract]

Schedule of Changes in Components of Accumulated Other Comprehensive Income (Loss)

For the nine months ended October 31, 2023 and 2022, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands):


	Foreign Currency Translation Adjustments		Unrealized Gain (Loss) on Marketable Securities		Accumulated Other Comprehensive Income (Loss)
Balance as of January 31, 2023	$	8,231	$	(619)	$	7,612
Other comprehensive (loss) income, net of tax	(4,713)		259		(4,454)
Balance as of October 31, 2023	$	3,518	$	(360)	$	3,158


	Foreign Currency Translation Adjustments		Unrealized Gain (Loss) on Marketable Securities		Accumulated Other Comprehensive Income (Loss)
Balance as of January 31, 2022	$	11,234	$	(335)	$	10,899
Other comprehensive loss, net of tax	(3,321)		(625)		(3,946)
Balance as of October 31, 2022	$	7,913	$	(960)	$	6,953

Equity Incentive Plans and Stock-Based Compensation (Tables)

9 Months Ended

Oct. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

Stock option activity during the nine months ended October 31, 2023 was as follows:


	Stock Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2023	13,898	$	3.32	7.7	$	169,324
Granted	2,763	$	0.10
Exercised	(3,559)	$	1.52
Forfeited	(361)	$	0.51
Outstanding as of October 31, 2023	12,741	$	3.20	7.6	$	158,811

Vested and exercisable as of October 31, 2023	6,252	$	3.68	6.4	$	74,680

Schedule of RSU Activity

RSU activity during the nine months ended October 31, 2023 was as follows:


	RSUs (in thousands)	Weighted-Average Grant Date Fair Value Per Share
Unvested as of January 31, 2023	36,785	$	22.48
Granted	17,615	$	16.54
Vested	(13,773)	$	20.47
Forfeited	(6,569)	$	23.46
Unvested as of October 31, 2023	34,058	$	20.03

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands):


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
Cost of subscription services revenue	$	3,791	$	2,844	$	10,778	$	8,901
Cost of professional services and other revenue	2,764		2,557		8,546		8,959
Sales and marketing	37,760		30,763		109,890		117,410
Research and development	30,604		23,435		88,448		73,559
General and administrative	20,961		21,492		65,363		61,968
Total	$	95,880	$	81,091	$	283,025	$	270,797

Net Loss Per Share Attributable to Common Stockholders (Tables)

9 Months Ended

Oct. 31, 2023

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts):


	Three Months Ended October 31,
	2023				2022
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(26,951)	$	(4,586)	$	(49,073)	$	(8,651)



Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	484,583		82,453		467,711		82,453
Net loss per share attributable to common stockholders, basic and diluted	$	(0.06)	$	(0.06)	$	(0.10)	$	(0.10)


	Nine Months Ended October 31,
	2023				2022
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(105,657)	$	(18,142)	$	(255,266)	$	(45,397)



Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	480,198		82,453		463,634		82,453
Net loss per share attributable to common stockholders, basic and diluted	$	(0.22)	$	(0.22)	$	(0.55)	$	(0.55)

Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share

Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands):


	Three Months Ended October 31,
	2023		2022
	Class A	Class B	Class A	Class B

Unvested RSUs	36,911	—	31,022	—
Outstanding stock options	13,207	—	13,812	—
Shares subject to repurchase from RSAs and early exercised stock options	52	—	104	—
Shares issuable under ESPP	714	—	936	—
Returnable shares issued in connection with business acquisition	274	—	427	—
Total	51,158	—	46,301	—


	Nine Months Ended October 31,
	2023		2022
	Class A	Class B	Class A	Class B
Unvested RSUs	38,137	—	29,307	—
Outstanding stock options	13,764	—	13,913	—
Shares subject to repurchase from RSAs and early exercised stock options	56	—	355	—
Shares issuable under ESPP	762	—	851	—
Returnable shares issued in connection with business acquisition	374	—	149	—
Total	53,093	—	44,575	—

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gain (losses)	$ 4.3	$ (0.4)	$ 2.9	$ (2.6)
Customer Concentration Risk \| Accounts Receivable \| Customer One
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			12.00%
US, European Union (“EU”) Countries, and Japan \| Geographic Concentration Risk \| Cash and Cash Equivalents
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			93.00%		98.00%

Revenue Recognition - Disaggregation of Revenue by Geographical Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Disaggregation of Revenue [Line Items]
Amount	$ 325,921	$ 262,744	$ 902,819	$ 750,032
Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	100.00%	100.00%	100.00%	100.00%
Americas
Disaggregation of Revenue [Line Items]
Amount	$ 174,226	$ 147,312	$ 437,396	$ 382,440
Americas \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	53.00%	56.00%	48.00%	51.00%
Europe, Middle East, and Africa
Disaggregation of Revenue [Line Items]
Amount	$ 93,782	$ 65,880	$ 271,722	$ 205,004
Europe, Middle East, and Africa \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	29.00%	25.00%	30.00%	27.00%
Asia-Pacific
Disaggregation of Revenue [Line Items]
Amount	$ 57,913	$ 49,552	$ 193,701	$ 162,588
Asia-Pacific \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	18.00%	19.00%	22.00%	22.00%
United States \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	48.00%	52.00%	44.00%	47.00%
Japan \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	7.00%	7.00%	10.00%	10.00%

Revenue Recognition - Deferred Revenue and Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized			$ 331,100	$ 268,800
Deferred contract acquisition costs	$ 21,600	$ 16,100	$ 52,828	$ 37,967

Revenue Recognition - Remaining Performance Obligations (Details) $ in Millions	Oct. 31, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 994.6
Billed Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	538.4
Unbilled Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 456.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-11-01
Disaggregation of Revenue [Line Items]
Remaining performance obligations, percentage	60.00%
Remaining performance obligations, period	12 months

Marketable Securities - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 814,459	$ 358,335
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(362)	(619)
Estimated Fair Value	814,097	357,716
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	23,853	62,470
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	23,853	62,470
Treasury bills and U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	602,927	234,848
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(150)	(308)
Estimated Fair Value	602,777	234,540
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	5,625	46,684
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(14)	(198)
Estimated Fair Value	5,611	46,486
Municipal bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,000	6,374
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(2)	(66)
Estimated Fair Value	998	6,308
Agency bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	181,054	7,959
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(196)	(47)
Estimated Fair Value	$ 180,858	7,912
Cash and cash equivalents \| Treasury bills
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		10,000
Estimated Fair Value		$ 10,000

Marketable Securities - Additional Information (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable securities with contractual maturities of one year or more	$ 0	$ 2,942
Prepaid Expenses and Other Current Assets
Debt Securities, Available-for-sale [Line Items]
Interest receivable	$ 3,300	$ 3,500

Fair Value Measurement (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Financial assets:
Total marketable securities	$ 814,097	$ 357,716
Commercial paper
Financial assets:
Total marketable securities	23,853	62,470
Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	602,777	234,540
Corporate bonds
Financial assets:
Total marketable securities	5,611	46,486
Municipal bonds
Financial assets:
Total marketable securities	998	6,308
Agency bonds
Financial assets:
Total marketable securities	180,858	7,912
Recurring
Financial assets:
Total cash equivalents	468,683	329,769
Total marketable securities	814,097	357,716
Total	1,282,780	687,485
Recurring \| Money market
Financial assets:
Total cash equivalents	468,683	319,801
Recurring \| Treasury bills
Financial assets:
Total cash equivalents		9,968
Recurring \| Commercial paper
Financial assets:
Total marketable securities	23,853	62,470
Recurring \| Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	602,777	234,540
Recurring \| Corporate bonds
Financial assets:
Total marketable securities	5,611	46,486
Recurring \| Municipal bonds
Financial assets:
Total marketable securities	998	6,308
Recurring \| Agency bonds
Financial assets:
Total marketable securities	180,858	7,912
Recurring \| Level 1
Financial assets:
Total cash equivalents	468,683	329,769
Total marketable securities	783,635	242,452
Total	1,252,318	572,221
Recurring \| Level 1 \| Money market
Financial assets:
Total cash equivalents	468,683	319,801
Recurring \| Level 1 \| Treasury bills
Financial assets:
Total cash equivalents		9,968
Recurring \| Level 1 \| Commercial paper
Financial assets:
Total marketable securities	0	0
Recurring \| Level 1 \| Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	602,777	234,540
Recurring \| Level 1 \| Corporate bonds
Financial assets:
Total marketable securities	0	0
Recurring \| Level 1 \| Municipal bonds
Financial assets:
Total marketable securities	0	0
Recurring \| Level 1 \| Agency bonds
Financial assets:
Total marketable securities	180,858	7,912
Recurring \| Level 2
Financial assets:
Total cash equivalents	0	0
Total marketable securities	30,462	115,264
Total	30,462	115,264
Recurring \| Level 2 \| Money market
Financial assets:
Total cash equivalents	0	0
Recurring \| Level 2 \| Treasury bills
Financial assets:
Total cash equivalents		0
Recurring \| Level 2 \| Commercial paper
Financial assets:
Total marketable securities	23,853	62,470
Recurring \| Level 2 \| Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	0	0
Recurring \| Level 2 \| Corporate bonds
Financial assets:
Total marketable securities	5,611	46,486
Recurring \| Level 2 \| Municipal bonds
Financial assets:
Total marketable securities	998	6,308
Recurring \| Level 2 \| Agency bonds
Financial assets:
Total marketable securities	0	0
Recurring \| Level 3
Financial assets:
Total	$ 0	$ 0

Business Acquisition - Summary of Total Purchase Consideration (Details) - USD ($) $ in Thousands, shares in Millions		9 Months Ended
	Jul. 29, 2022	Oct. 31, 2023	Oct. 31, 2022
Business Acquisition [Line Items]
Loan notes issued in connection with business acquisitions		$ 0	$ 11,433
Re:infer
Business Acquisition [Line Items]
Cash paid at closing	$ 30,117
Fair value of Class A common stock issued at closing (0.2 million shares)	2,965
Working capital adjustment	66
Total purchase consideration	$ 44,581
Stock issued at closing (in shares)	0.2
Re:infer \| First Anniversary of Closing
Business Acquisition [Line Items]
Loan notes issued in connection with business acquisitions	$ 5,863
Re:infer \| Second Anniversary of Closing
Business Acquisition [Line Items]
Loan notes issued in connection with business acquisitions	$ 5,570

Business Acquisition - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions		9 Months Ended
	Jul. 29, 2022	Oct. 31, 2023	Jan. 31, 2023
Business Acquisition [Line Items]
Purchase price allocation to goodwill		$ 87,293	$ 88,010
Re:infer
Business Acquisition [Line Items]
Total purchase consideration	$ 44,581
Stock issued at closing subject to clawback provisions (in shares)	0.4
Purchase price allocation to goodwill	$ 34,351
Goodwill deductible for tax purposes	0
Re:infer \| Common Stock
Business Acquisition [Line Items]
Unrecognized compensation expense	$ 7,600	$ 4,500
Weighted-average remaining period	3 years	1 year 9 months 18 days

Business Acquisition - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023	Jul. 29, 2022
Business Acquisition [Line Items]
Goodwill	$ 87,293	$ 88,010
Re:infer
Business Acquisition [Line Items]
Net tangible assets			$ 300
Intangible assets			13,100
Goodwill			34,351
Total assets acquired			47,751
Deferred tax liabilities assumed			(3,170)
Total			$ 44,581

Business Acquisition - Summary of Components of Identifiable Intangible Assets Acquired and Their Estimated Useful Lives (Details) - Re:infer $ in Thousands	Jul. 29, 2022 USD ($)
Business Acquisition [Line Items]
Fair Value	$ 13,100
Developed technology
Business Acquisition [Line Items]
Fair Value	$ 10,000
Estimated Useful Life	5 years
Customer relationships
Business Acquisition [Line Items]
Fair Value	$ 3,100
Estimated Useful Life	3 years

Intangible Assets and Goodwill - Summary of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 37,878	$ 38,194
Accumulated Amortization	(21,418)	(15,184)
Intangible Assets, Net	16,460	23,010
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	28,241	28,517
Accumulated Amortization	(15,206)	(11,095)
Intangible Assets, Net	$ 13,035	$ 17,422
Weighted-Average Remaining Useful Life (in years)	3 years	3 years 6 months
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 8,135	$ 8,174
Accumulated Amortization	(5,577)	(3,601)
Intangible Assets, Net	$ 2,558	$ 4,573
Weighted-Average Remaining Useful Life (in years)	1 year 4 months 24 days	2 years
Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 271	$ 272
Accumulated Amortization	(257)	(233)
Intangible Assets, Net	$ 14	$ 39
Weighted-Average Remaining Useful Life (in years)	4 months 24 days	1 year 2 months 12 days
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 1,231	$ 1,231
Accumulated Amortization	(378)	(255)
Intangible Assets, Net	$ 853	$ 976
Weighted-Average Remaining Useful Life (in years)	7 years 2 months 12 days	7 years 8 months 12 days

Intangible Assets and Goodwill - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of acquired intangible assets	$ 2.1	$ 2.1	$ 6.4	$ 4.8

Intangible Assets and Goodwill - Summary of Expected Future Amortization Expenses Related to Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of year ending January 31, 2024	$ 2,123
2025	6,538
2026	4,004
2027	2,369
2028	1,123
Thereafter	303
Intangible Assets, Net	$ 16,460	$ 23,010

Intangible Assets and Goodwill - Summary of Changes in Carrying Amounts of Goodwill (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 88,010
Effect of foreign currency translation	(717)
Ending Balance	$ 87,293

Operating Leases - Additional Information (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Lessee, Lease, Description [Line Items]
Non-cancellable commitments for operating leases that have not yet commenced	$ 500
Current operating lease liabilities	$ 6,905	$ 6,997
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Minimum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	14 years

Operating Leases - Summary of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Leases [Abstract]
Operating lease cost	$ 3,364	$ 3,060	$ 9,663	$ 8,555
Short-term lease cost	1,225	1,509	3,845	4,552
Variable lease cost	493	362	1,639	885
Sublease income	(426)	(532)	(1,491)	(1,597)
Total	$ 4,656	$ 4,399	$ 13,656	$ 12,395

Operating Leases - Weighted Average Lease Term and Discount Rate (Details)	Oct. 31, 2023	Jan. 31, 2023
Leases [Abstract]
Weighted-average remaining lease term (years)	11 years 2 months 12 days	12 years 1 month 6 days
Weighted-average discount rate (as a percent)	7.00%	7.00%

Operating Leases - Summary of Future Undiscounted Lease Payments for Operating Lease Liabilities (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Leases [Abstract]
Remainder of year ending January 31, 2024	$ 1,849
2025	12,284
2026	10,173
2027	9,432
2028	8,748
Thereafter	49,931
Total operating lease payments	92,417
Less: imputed interest	(27,825)
Total operating lease liabilities	$ 64,592

Operating Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 3,486	$ 1,721	$ 9,646	$ 5,278
Operating lease ROU assets obtained in exchange for new operating lease liabilities	$ 4,139	$ 5,769	$ 8,820	$ 8,659

Condensed Consolidated Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses and service credits	$ 65,755	$ 67,794
Other current assets	25,469	26,356
Prepaid expenses and other current assets	$ 91,224	$ 94,150

Condensed Consolidated Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 57,308	$ 56,976
Less: accumulated depreciation	(34,804)	(27,931)
Property and equipment, net	22,504	29,045
Computers and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	28,164	28,450
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	21,860	19,622
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,751	6,485
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 533	$ 2,419

Condensed Consolidated Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 2.7	$ 2.2	$ 8.5	$ 6.0

Condensed Consolidated Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 25,079	$ 19,411
Withholding tax from employee equity transactions	6,950	3,772
Employee stock purchase plan withholdings	8,217	3,365
Payroll taxes and other benefits payable	6,722	7,644
Income tax payable	12,774	8,750
Value-added taxes payable	4,342	6,381
Operating lease liabilities, current	6,905	6,997
Deferred consideration for business acquisition, current	5,570	5,863
Payable for marketable securities purchase	9,747	3,588
Other	21,708	10,874
Accrued expenses and other current liabilities	$ 108,014	$ 76,645

Credit Facility (Details)	Oct. 30, 2020 USD ($)
Senior Secured Credit Facility \| HSBC Ventures USA Inc., Silicon Valley Bank, Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD
Line of Credit Facility [Line Items]
Maximum borrowing capacity under credit agreement	$ 200,000,000

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023	Nov. 10, 2022	Jun. 24, 2022
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding	$ 3,200		$ 3,200		$ 4,300
Defined contribution plan, contribution cost	3,300	$ 2,700	12,400	$ 11,400
Litigation Matters
Restructuring Cost and Reserve [Line Items]
Loss contingency accrual	0		0
Product Liability Contingencies
Restructuring Cost and Reserve [Line Items]
Loss contingency accrual	$ 0		0
Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Expected percentage reduction of global workforce						6.00%	5.00%
Restructuring costs incurred			$ 2,631

Commitments and Contingencies - Accrued Restructuring Costs (Details) - Employee Termination Benefits $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Restructuring Reserve [Roll Forward]
Accrued restructuring costs, beginning balance	$ 3,889
Restructuring costs incurred	2,631
Amount paid	(6,072)
Accrued restructuring costs, ending balance	$ 448

Commitments and Contingencies - Schedule of Non-Cancelable Purchase Obligations (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of year ending January 31, 2024	$ 11,164
2025	91,225
2026	64,667
2027	21,679
2028	8,245
Thereafter	0
Total	$ 196,980

Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands	1 Months Ended	3 Months Ended			9 Months Ended
	Nov. 28, 2023	Oct. 31, 2023	Apr. 30, 2023	Jul. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Sep. 01, 2023
Class of Stock [Line Items]
Charitable contribution recorded as expense					$ 4,215,000	$ 5,499,000
Common Stock \| Class A Common Stock
Class of Stock [Line Items]
Repurchase authorized							$ 500,000,000
Repurchased of common shares (in shares)		3,200			3,200
Average price of common shares (in dollar per share)		$ 16.26			$ 16.26
Common stock shares reserved to fund social impact and environmental, social and governance initiatives (in shares)		2,800			2,800
Charitable donation of Class A common stock (in shares)			281	300	300
Common Stock \| Class A Common Stock \| Subsequent Event
Class of Stock [Line Items]
Repurchased of common shares (in shares)	1,700
Average price of common shares (in dollar per share)	$ 17.38

Stockholders' Equity - Summary of Changes In Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2023	Oct. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 1,983,366	$ 1,955,537	$ 1,920,158	$ 1,849,549	$ 1,880,194	$ 1,921,917	$ 1,920,158	$ 1,921,917
Other comprehensive (loss) income, net of tax	(8,348)	1,432	2,462	(4,197)	709	(458)	(4,454)	(3,946)
Ending balance	1,961,213	1,983,366	1,955,537	1,859,824	1,849,549	1,880,194	1,961,213	1,859,824
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	11,506	10,074	7,612	11,150	10,441	10,899	7,612	10,899
Other comprehensive (loss) income, net of tax	(8,348)	1,432	2,462	(4,197)	709	(458)
Ending balance	3,158	$ 11,506	10,074	6,953	$ 11,150	10,441	3,158	6,953
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			8,231			11,234	8,231	11,234
Other comprehensive (loss) income, net of tax							(4,713)	(3,321)
Ending balance	3,518			7,913			3,518	7,913
Unrealized Gain (Loss) on Marketable Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			$ (619)			$ (335)	(619)	(335)
Other comprehensive (loss) income, net of tax							259	(625)
Ending balance	$ (360)			$ (960)			$ (360)	$ (960)

Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		1 Months Ended			3 Months Ended	9 Months Ended
	Jul. 29, 2022	Jul. 31, 2023	Apr. 30, 2021	Sep. 30, 2020	Jul. 31, 2022	Oct. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value of stock options granted (in dollars per share)						$ 16.56
Intrinsic value of stock options exercised						$ 55,400
Cost not yet recognized for unvested options						$ 113,000
Restricted stock awards issued, value					$ 1
Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock issued at closing subject to clawback provisions (in shares)	400
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period						2 years 3 months 18 days
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period						2 years 4 months 24 days
Fair value of RSUs vested						$ 236,200
Unrecognized compensation expense						$ 612,600
Grant date fair value per share (in dollars per share)						$ 16.54
Granted (in shares)						17,615
Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period						10 months 24 days
Unrecognized compensation expense						$ 900
Restricted stock awards issued (in shares)				100
Grant date fair value per share (in dollars per share)				$ 33.22
Restricted stock awards issued, value				$ 4,000
Award vesting period				4 years
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date fair value per share (in dollars per share)		$ 18.08
Granted (in shares)		100
Performance Shares \| Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percent)		0.00%
Performance Shares \| Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percent)		100.00%
Performance Shares \| Share-Based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights (percent)		200.00%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)			15,500
Period of shares automatically increase			10 years
Percentage of total number of shares			1.00%
Number of shares authorized (in shares)						21,500
Weighted-average remaining period						1 month 6 days
Unrecognized compensation expense						$ 700
Shares purchased (in shares)						800
Purchase price (in dollars per share)						$ 11.19
Common Stock \| Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period	3 years					1 year 9 months 18 days
Unrecognized compensation expense	$ 7,600					$ 4,500
Class A Common Stock \| ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock, offering date, percent of market price			85.00%
Purchase price of common stock, purchase date, percent of market price			85.00%
2021 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of shares automatically increase			10 years
Percentage of total number of shares			5.00%
2021 Stock Plan \| Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)						173,700

Equity Incentive Plans and Stock-Based Compensation - Summary of Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2023 USD ($) $ / shares shares	Jan. 31, 2023 USD ($) $ / shares shares
Stock Options
Outstanding, beginning balance (in shares) \| shares	13,898
Granted (in shares) \| shares	2,763
Exercised (in shares) \| shares	(3,559)
Forfeited (in shares) \| shares	(361)
Outstanding, ending balance (in shares) \| shares	12,741	13,898
Vested and exercisable, Number of Stock Options (in shares) \| shares	6,252
Weighted-Average Exercise Price
Outstanding, beginning balance (in dollars per share) \| $ / shares	$ 3.32
Granted (in dollars per share) \| $ / shares	0.10
Exercised (in dollars per share) \| $ / shares	1.52
Forfeited (in dollars per share) \| $ / shares	0.51
Outstanding, ending balance (in dollars per share) \| $ / shares	3.20	$ 3.32
Vested and exercisable, Weighted-Average Exercise Price (in dollars per share) \| $ / shares	$ 3.68
Outstanding, Weighted-Average Remaining Contractual Life (years)	7 years 7 months 6 days	7 years 8 months 12 days
Vested and exercisable, Weighted-Average Remaining Contractual Life (years)	6 years 4 months 24 days
Outstanding, Aggregate Intrinsic Value \| $	$ 158,811	$ 169,324
Vested and exercisable, Aggregate Intrinsic Value \| $	$ 74,680

Equity Incentive Plans and Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units shares in Thousands	9 Months Ended
	Oct. 31, 2023 $ / shares shares
RSUs
Unvested, beginning balance (in shares) \| shares	36,785
Granted (in shares) \| shares	17,615
Vested (in shares) \| shares	(13,773)
Forfeited (in shares) \| shares	(6,569)
Unvested, ending balance (in shares) \| shares	34,058
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in dollars per share) \| $ / shares	$ 22.48
Granted (in dollars per share) \| $ / shares	16.54
Vested (in dollars per share) \| $ / shares	20.47
Forfeited (in dollars per share) \| $ / shares	23.46
Unvested, ending balance (in dollars per share) \| $ / shares	$ 20.03

Equity Incentive Plans and Stock-based Compensation - Summary of Stock-Based Compensation Expense in Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 95,880	$ 81,091	$ 283,025	$ 270,797
Cost of revenue \| Subscription services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	3,791	2,844	10,778	8,901
Cost of revenue \| Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,764	2,557	8,546	8,959
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	37,760	30,763	109,890	117,410
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	30,604	23,435	88,448	73,559
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 20,961	$ 21,492	$ 65,363	$ 61,968

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Valuation Allowance [Line Items]
Provision for income taxes	$ 3,926	$ 1,182	$ 11,388	$ 10,061
Effective tax rate	(14.20%)	(2.10%)	(10.10%)	(3.50%)
Unrecognized tax benefits which would impact the effective tax rate if recognized	$ 2,300		$ 2,300
Liability pertaining to uncertain tax positions	1,500		1,500
Japan
Valuation Allowance [Line Items]
Deferred tax valuation allowance	$ 0		$ 0

Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2023	Oct. 31, 2022
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (31,537)	$ (60,361)	$ (31,901)	$ (57,724)	$ (120,378)	$ (122,561)	$ (123,799)	$ (300,663)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	567,036			550,164			562,651	546,087
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	567,036			550,164			562,651	546,087
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)
Class A Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (26,951)			$ (49,073)			$ (105,657)	$ (255,266)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	484,583			467,711			480,198	463,634
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	484,583			467,711			480,198	463,634
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)
Class B Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (4,586)			$ (8,651)			$ (18,142)	$ (45,397)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	82,453			82,453			82,453	82,453
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	82,453			82,453			82,453	82,453
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)			$ (0.10)			$ (0.22)	$ (0.55)

Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Class A Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	51,158	46,301	53,093	44,575
Class A Common Stock \| Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	36,911	31,022	38,137	29,307
Class A Common Stock \| Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	13,207	13,812	13,764	13,913
Class A Common Stock \| Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	52	104	56	355
Class A Common Stock \| Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	714	936	762	851
Class A Common Stock \| Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	274	427	374	149
Class B Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B Common Stock \| Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B Common Stock \| Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B Common Stock \| Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B Common Stock \| Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B Common Stock \| Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0

Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Related Party Transaction [Line Items]
Operating expenses	$ 331,820	$ 286,967	$ 940,060	$ 920,808
Related Party
Related Party Transaction [Line Items]
Operating expenses	$ 0	$ 0	$ 0	$ 1,900